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Abstract: 
Macroautophagy or canonical autophagy, referred to as autophagy hereafter, delivers damaged 
proteins and organelles to lysosomes for degradation and plays important roles in maintaining tissue 
homeostasis by reducing tissue damage.  During autophagy substrates are sequestered in double-
membraned autophagosomes within the cytoplasm which recruit LC3 to facilitate fusion with 
lysosomes.  
A related pathway, called non-canonical autophagy, conjugates LC3 to single-membraned 
endosomes, phagosomes or lysosomes during the entry of extracellular material.  Examples include 
engulfment of neighbouring cells by entosis, uptake of apoptotic cells, and micropinocytosis.  In 
phagocytic cells, such as macrophages and dendritic cells, recruitment of LC3 to phagosomes occurs 
during pathogen uptake and is called LC3-associated phagocytosis (LAP).   
The relative roles played by autophagy and non-canonical autophagy ‘in vivo’ are poorly understood. 
Studies on autophagy in mice have relied on inactivation of essential autophagy proteins, however 
these proteins are also required for non-canonical autophagy, and mouse models are defective in 
both pathways.  The recruitment of LC3 to membranes during both, autophagy and non-canonical 
autophagy/ LAP, requires the E3 ligase-like activity of the ATG12–ATG5-ATG16L1 complex.  The WD 
domain of ATG16L1 is required for non-canonical autophagy and LAP, but is not required for 
autophagy. This finding was employed to create mice defective in non-canonical autophagy and LAP 
by removing WD domain from the Atg16L1 gene. These mice (called E230) expressed the glutamate 
residues at 226 and 230 positions in the coiled-coil domain (CCD) of ATG16L1 protein required for 
binding with WIPI2, an interaction needed for autophagy. A second mouse model was generated 
that lacked the E230 residue required for autophagy and was called E226. 
MEFs from E226 mice were defective in both autophagy and non-canonical autophagy.  E226 mice 
showed growth defects and analysis of liver, kidney, muscle and brain showed accumulation of 
autophagy substrates p62and LC3.  MEFs from the E230 mice were defective in non-canonical 
autophagy but could activate autophagy.  The E230 mice survived postnatal starvation and grew 
normally.  Liver, kidney, brain and muscle of E230 mice maintained levels of autophagy substrates 
p62 and LC3 that were the same as littermate controls. Tissue damage associated with loss of 
autophagy such as presence of p62 inclusions and inflammation were observed in tissue of E226 
mice but were absent from E230 mice.  This comparative study suggests that autophagy maintains 
tissue homeostasis in mice independently of the WD domain of ATG16L1required for non-canonical 
autophagy/LAP. A comparison of ATG5-ATG12-ATG16L1 complexes formed in liver and brain 
suggested that autophagy in the brain may be less dependent on strong interactions between WIPI2 
and ATG16L1 than in liver. It is possible that E226 mice, which lack E230 required for strong WIPI2 
binding, maintain autophagy in the brain to survive neonatal starvation.  
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Chapter-1 
Introduction 
1. Autophagy: 
Macroautophagy, hereafter referred as autophagy(Greek, auto = ‘self’, phagein = ‘to eat’) is a 
cellular recycling process that is conserved in eukaryotes from yeast to humans (1, 2)during which 
excess and damaged cytoplasmic materials (cargo) are captured in double membrane vesicles called 
autophagosomes which then fuse with lysosomes (autolysosomes) to degrade the cargo. The 
degradation products, which are mostly amino acids, get recycled in to cytoplasm to be utilised in 
metabolic pathways. The most common trigger of autophagy is amino acid starvation. Other than 
the induction of autophagy by starvations, cells can use low levels of constitutive or general 
autophagy to clear damaged organelles, proteins and aggregates to maintain tissue homeostasis. 
Hence, dysfunctional autophagy has been associated with various conditions like neurodegenerative 
disorders, cancer, ageing, inflammatory diseases etc (3). Autophagy is also involved in the removal of 
pathogens (xenophagy) and plays role in providing immune-protection (3). 
1.1. The core components of autophagy.   
To date more than 30 autophagy related (Atg) genes have been identified.  These were first 
identified in yeast and many orthologs have been identified in higher eukaryotes.  Autophagy can be 
viewed as a series of sequential steps (Figure 1A) involving signalling events that initiate 
autophagosome formation (phagophores nucleation), the expansion and closure of the 
autophagosome during cargo capture and fusion of the autophagosome with the lysosome (4).   
1.1.1 Autophagosome Initiation (phagophore nucleation).  
Initiation of autophagy is regulated by the mammalian/mechanistic target of rapamycin complex 
(mTOR).  The mTOR kinase senses amino acid levels, and when amino acids levels are high, mTOR 
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Figure 1: The process of autophagy: A. Starvation and other stress signals activate ULK1 complex 
(ULK1, ATG13, FIP200 & ATG101) (initiation) to phosphorylate and recruit components of class III 
PI3P kinase complex I (VPS34, Beclin 1, ATG14, AMBRA 1 and p115) on to isolation membrane at PAS 
(phagophore assembly site) region of endoplasmic reticulum (ER) (phagophore nucleation). PI3P 
kinase complex generated PI3P recruit further proteins like DFCP1 and WIPI2 on expanding 
phagophore at omegasomes (phagophore expansion). Various cellular sources provide membrane 
during phagophore expansion. WIPI2 recruits ATG3 via ATG12-ATG5-ATG16L1 complex to mediate 
LC3 conjugation to membrane associated PE. WIPI2 interaction with ATG16L1 is essential for this 
process (highlighted in B). The cargo sequestration within growing double membrane of phagophore 
is performed by the help of various mechanisms involving tag proteins like ubiquitin (ub) or cargo 
receptor protein binding cargo/ tag and PE conjugated LC3. Once completely formed the double 
membraned phagophore, called autophagosome, fuses with lysosome to mature in autolysosome. 
Cargo in autolysosome gets degraded my acidic hydrolases present in the lumen and the 
degradation products get recycled in the cytoplasm. B. ATG16L1 interacts with WIPI2 on membrane 
to bring ATG3 through ATG12–ATG5-ATG16L1 complex interaction. Figure taken from (4). 
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phosphorylates proteins required for m-RNA translation to increase protein synthesis.  At the same 
time active mTOR phosphorylates and inhibits the ULK1 complex required for autophagy.  The ULK1 
complex contains ULK1/2, ATG13 and FIP200 and inactivation of mTOR during starvation leads to 
dissociation from mTOR and activation of the ULK1/2 kinase which phosphorylates ATG13 and 
FIP200 to initiate autophagosome formation which begins at specific area on endoplasmic reticulum 
(ER) called omegasomes that are PtIns3P rich and marked by PtIns3P-binding protein zinc-finger 
FYVE domain-containing protein 1 (DECP also known as ZFYVE1) (Figure 1A). Nascent 
autophagosomes are termed as phagophores and area of phagophore nucleation are referred as 
phagophores assembly site (PAS).Other than ER, ER-mitochondria contact sites, ER-plasma 
membrane contact sites (5, 6) as well as organelles like golgi complex, plasma membrane and 
recycling endosomes were also recently implicated as PAS (7) (Figure 1A). 
1.1. 2 Phagophore expansion.  The activated Unc-51-like kinase 1 (ULK1) complex (consisting of 
ULK1, autophagy-related protein 13 (ATG13), RB1-inducible coiled-coil protein 1 (FIP200) and 
ATG101) formed in response to low amino acids recruits the Class III PI3 kinase complex (consisting 
of class III PI3K, vacuolar protein sorting 34 (VPS34), Beclin1, ATG14, activating molecule in Beclin1-
regulated autophagy protein 1 (AMBRA1) and general vesicular transport factor (p115) ) to 
membranes that will initiate autophagosome expansion during autophagosome formation (Figure 1).  
Most autophagosomes are thought to originate from the endoplasmic reticulum (ER) but 
mitochondria, plasma membrane, recycling endosomes, Golgi complex and ATG9 containing vesicles 
have also been implicated as membrane source provider during expansion of phagophores (Figure 
1A).  The PI3 kinase activity of Vps34 kinase phosphorylates inositol lipids to generate local 
phosphatidylinositol-3-phosphate (PI3P) at particular structure of ER called Omegasome (Figure 1A). 
These PI3Ps provide a signal for autophagy proteins WD repeat domain phosphoinositide-interacting 
protein 2 (WIPI2) and zinc-finger FYVE domain-containing protein 1 (DFCP1) required for 
autophagosome expansion (Figure 1A & B).  These proteins carry FYVE domains that bind 
phosphorylated inositols generated by Vps34.  The most important is WIPI2 which recruits 
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downstream autophagy proteins ATG5, ATG12 and ATG16L1 that facilitate incorporation of LC3 into 
the limiting membrane of the autophagosome. WIPI2 binds directly to ATG16L1 and in this way 
brings ATG16L1 to membranes phosphorylated by Vps34 (Figures 1B).   
The conjugation of LC3 to the PE of growing phagophore membrane follows the same pattern as 
ubiquitin proteasome system (UPS) for the tagging and degradation of proteins (8). UPS involves E1, 
E2 and E3 enzymes for activation, conjugation and ligation steps, respectively, for coupling of 
proteins to ubiquitin required for degradation (8) (Figure 2A). The LC3 conjugation is preceded by 
cysteine protease ATG4 mediated processing of C-terminal of LC3 to expose glycine residue essential 
for the process (Figure 2B). This processed form of LC3 gets activated by E1-like enzyme ATG7 before 
its conjugation to membrane associated PE by the activity of ATG3 (Figure 2B). In this process a 
cytoplasmic free form of LC3 (LC3-I) gets converted in to membrane anchored form of LC3 (LC3-II) 
(Figure 2B). The E1 like enzyme ATG7 also activates ATG12 to form ATG5–ATG12 conjugate with the 
help of E2 like enzyme ATG10 (Figure 2C). The E3 like enzyme activity of ATG5–ATG12 conjugate 
stimulates ATG3 for conjugation of LC3 to membrane associated PE (Figure2C). The ATG5–ATG12 
conjugate associates with ATG16L1 to form a complex which eventually localises to phagophore’s 
membrane due to interaction between ATG16L1 and WIPI2 (Figures 1B).  This conjugation system 
works similarly for all the ATG8 family proteins like LC3 and γ-aminobutyric acid receptor- associated 
proteins (GABARAPs). Different isoforms of ATG4 operate on the processing of ATG8 family proteins. 
Processing of LC3 is done by ATG4B whereas GABARAPs are processed by ATG4A. This conjugation 
process facilitates phagophores expansion and possibly closure as well. 
The cysteine protease ATG4 also plays role in limiting phagophores expansion by de-conjugating LC3 
from its membrane. This way LC3 gets recycled in the next expansion step. This critical two-way 
activity (LC3 processing and de-conjugation) of ATG4 is tightly regulated by methods like 
mitochondria generated ROS or de-phosphorylation by ULK-1 (9-11). 
 
15 | P a g e  
 
 
 
Figure 2: Similarity between ubiquitin-proteasome system (UPS) and autophagy: Short half-life 
proteins in cells get marked with ubiquitin (Ub) to be directed for degradation. This conjugation 
process involves three sequential steps in which Ub gets finally conjugated to the target protein as 
marker for degradation. A. The three steps are mediated by E1, E2 and E3 enzymes for activation, 
conjugation and final ligation of Ub to the protein to be degraded, sequentially. LC3 conjugation to 
existing membrane of phagosomes, endolysosomes or autophagosomes happens in similar way 
where different proteins show E1, E2 or E3 like activity. B. The ATG4 mediated activation of LC3 
initiates sequential activities of E1 like ATG7, E2 like ATG3 and finally E3 like ATG12–ATG5 conjugate 
to transfer LC3 to membrane associated PE. C. E3 like ATG12–ATG5 conjugate is created by similar 
sequential activities of E1 and E2 like ATG7 and ATG10 respectively, on ATG12 to make a covalent 
conjugation with ATG5 required for final step of LC3 conjugation to PE on membrane. Figure 
modified from (8). 
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1.1.3 Cargo sequestration. 
The membrane conjugated LC3 has more roles than just phagophores expansion. All the ATG8 family 
proteins like LC3 bind with a specific motif (W/F/Y1X2X3L/I/V4) present on other proteins called LC3 
interacting regions (LIRs). Various cargo receptor proteins (also called adapter proteins) like 
sequestosome 1 (p62/SQSTM1), B-box coiled coil motif containing neighbour of BRCA1 gene 1 
protein (NBR1) and nuclear dot protein 52 (NDP52) also known as calcium-binding and coiled-coil 
domain-containing protein 2 (CALCOCO2) bind to the cargo at one and LC3-II to another end acting 
like a bridge to help in cargo capturing (Figures 1A& 3). Often these cargo receptors bind to “eat me” 
signals (e.g. ubiquitin or galectins) displayed on the cargo surface to form the bridge (Figures 1A & 
3). This process of capturing “earmarked” cargo for autophagic degradation is termed as selective 
autophagy which is different from the starvation induced “bulk autophagy” which is also known as 
general autophagy. 
Selective autophagy is named differently for every cargo it chooses to degrade by suffixing with the 
initials of the target cargo’s name e.g. mitophagy (for mitochondria), aggrephagy (protein 
aggregates), xenophagy (intracellular pathogens), ribophagy (ribosomes), ERphagy (ER), pexophagy 
(peroxisomes), lipophagy (lipid droplets), nucleophagy (part of nucleus) and likewise. The process of 
selectively capturing specific cargo follows different mechanisms employing various proteins based 
on the choice of cargo (Figure 3) (12).In most known cases the selected cargo either directly binds to 
membrane anchored LC3-II via its own LIR motif or first gets labelled with a tag like ubiquitin which 
bind to a receptor protein that finally binds to LC3-II (Figure 3) (12). These receptor proteins carry 
both a LIR motif and an ubiquitin-binding domain hence acting as a bridge between cargo and LC3-II. 
In case of cargo comprising components of inflammasome or IFN signalling, TRIM family receptor 
proteins, bridge the gap between cargo and GABARAP without ubiquitin tagging (13) (Figure 3).The 
process of selective autophagy has more physiological relevance than bulk autophagy which is more 
like a homeostasis mechanism. A tight regulation of the selective autophagy must be necessary as an 
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Figure 3: Cargo sequestration and selective autophagy: The figure shows various cargoes directed 
for degradation via autophagy, get sequestered in the autophagosome by various mechanisms. 
Different cargoes interact with membrane conjugated LC3/GABARAP for the sequestration process. 
Depending on cargo, this interaction can happen directly between cargo and LC3/ GABARAP or it can 
get facilitated by intermediate interaction with adaptor/receptor (p62/SQSTM1, NBR1, NDP52, 
OPTN etc.) proteins and/or tags (ubiquitin, galectin etc.). The involvement of additional tag and 
adaptor proteins make this process selective for specific cargoes and hence it is termed as selective 
autophagy which is different from non-specific or bulk autophagy. The figure also shows a non-
exhaustive list of known organelle specific LC3/ GABARAP binding proteins, Tags, adapter proteins 
and regulators. Figure taken from (12). 
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inappropriate display in space and time of any of the selectivity factor can lead to disturbed 
homeostasis. Mutation is various selective autophagy factors like receptor proteins has been 
associated with diseases like neurodegenerative disorders (p62/SQSTM1, optineurin/OPTN (14-17)), 
parkin/PRKN (18-20), PINK1 (21), TBK1 (22, 23)), inflammatory bowel disease (NDP52/ CALCOCO2) 
(24) and autoimmunity disorder (TRIM20) (25) etc. 
1.1.4 Autophagosome fusion with lysosomes:  
After closure, fully formed autophagosomes go through the process of maturation which starts with 
the stripping of all the proteins involved in phagophore expansion. The fusion of autophagosomes to 
lysosomes requires close positioning of both the structures which starts with the perinuclear 
clustering of lysosomes driven by intracellular pH change (26). Once completely formed, 
autophagosomes move towards perinuclear region by the help of motor protein dynein and kinesin 
which propels its centripetal movement along microtubule (27, 28) (Figure 4). Besides microtubule-
based motors, actin-based motors MYO6/ myosin VI and MYO1/myosin I also participate in this 
process (28-30) (Figure 4). Once they are in close proximity, for efficient fusion, autophagosomes 
gets tethered to lysosomes through various factors. These factors broadly fall in three categories: 
HOPS (homotypic fusion and protein sorting) complex, RAB7 and adaptors (EPG5, PLEKHM1, TECPR1) 
that link autophagosomal and lysosomal components to the core tethering or fusion machinery 
(Figure 4) (28). 
     The core tethering factor for autophagosome-lysosome fusion, the HPOS complex interacts with 
Q-SNARE STX17 to form a trans SNARE complex needed for fusion (28, 31, 32) (Figure 4). The fusion 
process is further aided by specificity provided by RAB7 and adaptors. The adaptors EPG5 binds to 
RAB7 present on the lysosomes and LC3-II of autophagosome providing specificity to the fusion 
process (Figure 4)(28). Similarly, the adaptor PLEKHM1 bridges the gap between autophagosome 
and lysosome by binding to HOBS complex, LC3-II and RAB7 of lysosome (Figure 4)(28). Another  
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Figure 4: Fusion of autophagosome with lysosome: Autophagosome move closer to lysosomes with 
the help of microtubule based motor proteins dynein, kinesin and actin based motor protein myosin 
(MYO6). Once placed in close proximity, the autophagosomes get tethered to lysosomes with the 
help of HOPS complex, RAB7 and adaptors PLEKHM1, EPG5 and TECPR1. Adapters provide specificity 
to the fusion process by binding directly or to different factors associated with autophagosomal 
(LC3, ATG12–ATG5) or lysosomal (RAB7) membranes. The final fusion process is mediated by fusion 
of SNARES on autophagosomes (STX17) and lysosomes (VAMP8, SNAP29) to form a trans-SNARE 
complex. Interaction of lipid molecules with various factors like Ptdins3P-TECHPR1 and CTTN 
(cortactin)-Ptdins(3,5)P2-CTTN, helps in the stabilisation of fusion complex. Figure taken from (28). 
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adaptor TECPR1 binds directly to the lysosome but via ATG12–ATG5 and Ptdins3P to autophagosome 
(28, 33) (Figure 4). 
  SNAREs are the core components of the fusion machinery. During membrane fusion R-SNAREs and 
Q-SNAREs on separate membranes assemble on to trans-SNARE complexes to provide necessary 
force for fusion. During autophagy autophagosomal Q-SNARE STX17 interacts with SNAP29 and the 
lysosomal R-SNARE VAMP8 to form a trans-SNARE complex to facilitate fusion (28, 34) (Figure 4). 
Many factors regulate the SNARE complex of autophagosome. ATG14 interacts with STX17 to 
stabilise the binary Q-SNARE complex STX17-SNAP29 on autophagosomes to promote fusion (28, 35) 
(Figure 4). 
Apart from all the above mentioned cytoskeletal elements, motor proteins, tethering factors, 
adaptor proteins and SNAREs, the membrane lipid molecule phosphatidylinositol (PI) also plays a key 
role in autophagosome-lysosome fusion. Among its seven different forms (phosphorylated and de-
phosphorylated), PtdIns3P, PtdIns4P and PtdIns(3,5)P2are required for autophagosome-lysosome 
fusion (33, 36-39). INPP5 of lysosome dephosphorylates PtdIns(3,5)P2to induce CTTN (cortactin) 
dependent actin filament stabilisation on lysosome, promoting autophagosome-lysosome fusion 
(Figure 4) (28). As mentioned earlier, PtdIns3P also plays an important role in the fusion process by 
binding to TECPR1 assisted by its interaction with ATG12–ATG5 (28, 33)(Figure 4).  
 At the end of this step, the outer membrane of autophagosome fuses with the membrane of 
lysosome and the single membraned vesicle gets delivered in to the lumen of autolysosome (fusion 
product of autophagosome and lysosome). In the lumen, the inner membrane of autophagosome 
gets digested by the action of lysosomal hydrolases and exposes the cargo for further degradation 
(40-42). At the end of cargo degradation, the generated products mainly amino acids and sugars gets 
transported out of autolysosome through lysosome efflux transporters leading to concomitant 
decrease in the volume of autolysosome. Autolysosomes are not permanent structure and 
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disintegrate at the end autophagy via a process dubbed as autophagic lysosome reformation (ALR) 
(43).     
1.2 Non-canonical autophagy and LC3-associated phagocytosis (LAP): 
Non-canonical autophagy and LC3-associated phagocytosis (LAP) uses the ubiquitin-like reactions of 
the ATG12–ATG5-ATG16L1 complex to conjugate LC3 to phosphatidylethanolamine (PE or PtdIn) in 
membranes of existing endolysosomes or endocytic vesicles containing extracellular or particulate 
materials to facilitate fusion with lysosomes (Figure 5A).This process is termed as LC3-associated 
phagocytosis (LAP) in phagocytic cells(e.g. macrophages, dendritic cells)where it leads to rapid 
removal of pathogens to modulate immune response (44-49). During canonical autophagy described 
above activation of the ULK1 complex (ULK1-ATG13-ATG101-FIP200) and class III PI3Kl complex leads 
to conjugation of LC3 to PE in cup-shaped phagophores that expands and seals engulfing cargoes 
within double-membraned autophagosomes (Figures 1A& 5B).During non-canonical autophagy, 
activation of the class III PI3Kl complex like UVRAG complex containing RUBICON, takes place 
without the aid of ULK1 complex leading to LC3-PE conjugation on pre-existing single membraned 
compartments that are not autophagosomes (Figures 5B & 6) (50).   
1.2.1 LC3-associated phagocytosis (LAP): LAP is activated by TLR signalling following recognition of 
pathogens encased inside phagosomes and subsequent activation of class III PI3K complex (Figure 6). 
This class III complex contains beclin1, VPS34, UVRAG and Rubicon (Figure 6) (50).  Recruitment of 
this complex on phagosomal membrane activates PtdIns3P production required for further 
recruitment of NADPH oxidase/NOX2 complex (Figure 6) (50).  The NOX2 complex assembly forms 
when intraphagosomal components (NOX2 and p22 PHOX2) are joined by cytosolic NOX2 
components (Rac1, p40 PHOX, p47 PHOX and p67 PHOX) (Figure 6) (50). The NOX2 assembly gets 
further stabilised by association with Rubicon (Figure 6). The stabilised NOX2 complex generates 
reactive oxygen species (ROS) which along with Ptdins3P recruit further downstream factors, same 
as required for autophagy (ATG7, ATG3, ATG12–ATG5-ATG16L1), for LC3 conjugation on the limiting  
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Figure 5: Difference between canonical and non-canonical autophagy/LAP: Autophagy and LAP 
both require membrane conjugation of LC3 via ATG16L1 to facilitate fusion with lysosomes. These 
processes slightly differ in their cargo selection and signalling events. A. LAP captures extracellular 
cargo (e.g. pathogen) in single membrane phagosome followed by LC3 lipidation on phagosome 
membrane.  During autophagy intracellular cargos are captured in double membrane 
autophagosomes which gets LC3 conjugated on both outer and inner membranes. B. Autophagy and 
LAP differ in their initial signalling events. During autophagy, inhibition of mTOR during starvation 
recruits UKL-1 (ATG13, ULK1, ATG101, FIP200) and class III PI3K (ATG14, Beclin 1, VPS 34) complexes 
to generate local PI3P pool on membranes required for WIPI interaction. On the other hand, LAP is 
positively regulated by TLR mediated signalling to recruit UVRAG complex (Beclin 1, UVRAG, VPS34 
and RUBICON) and NOX2 (NADPH oxidase 2) complex to generate PI3P and reactive oxygen species 
(ROS).   
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membrane of  phagosomes (Figure 6) (50). This conjugation facilitates fusion of pathogen containing 
phagosomes with lysosomes for degradation and antigen presentation (Figure 6).    
1.2.2 Non-canonical autophagy: During non-canonical autophagy, LC3 is recruited to endo-
lysosomal compartments in non-phagocytic cells during micropinocytosis, engulfment of 
neighbouring cells by entosis, lysosomotropic drug treatment and during the uptake of particulate 
material or apoptotic cells (47, 48, 51). 
1.2.3 Distinguishing between roles of autophagy and LAP: 
Various in vitro studies showed that mammalian cells evolved two similar pathways namely 
autophagy and LAP for pathogen removal (50, 52-56) and hence to maintain tissue homeostasis by 
reducing tissue damage, the relative importance of one over other is not known. Since both the 
processes are very similar and most of the genes involved are same, it is difficult to find out which 
process has more importance in vivo. To address this problem a common strategy would be to 
generate in vivo models deficient in either autophagy or LAP. Mice carrying complete knock out of 
proteins essential for autophagy die soon after birth as they cannot survive the starvation generated 
after loss of placental nutrition (57). The role played by autophagy ‘in vivo’, therefore, has been 
studied using tissue specific knock out of autophagy genes (57-61). Many tissue specific autophagy 
deficient mice survive the post-natal period but show multiple tissue abnormalities including 
accumulation of ubiquitin positive inclusions containing protein aggregates and high level of 
inflammation and tissue damage (57-61). Most of these tissue-specific knockout mice were 
generated by targeted loss of Atg3, Atg5, Atg7, Atg12 or Atg16L1 which are autophagy proteins that 
are also required for LAP (57-61). These studies, hence could not determine whether the tissue 
abnormalities were seen because of absence of autophagy or LAP or both. During the course of this 
PhD, in another study, LAP-deficient mice have been generated by deleting Rubicon/RUBCN to  
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Figure 6: Non-canonical autophagy or LC3 associated phagocytosis (LAP): Various extracellular 
particulate materials or pathogens bind to specific toll like receptors (TLRs) to activate the signalling 
which involves recruitment of class III PI3K complex containing Beclin 1, RUBICON, VPS34 and 
UVRAG. This UVRAG complex generates local pool of PI3P (Ptdins3P) which helps in the recruitment 
of cytoplasmic RAC1, p40 PHOX, p47 PHOX and p67 PHOX on to phagosome/endosome associated 
NOX2 and p22 PHOX to form NOX2 complex stabilised by RUBICON. The stable NOX2 complex 
produces reactive oxygen species (ROS) which along with PI3P, generated by activated UVRAG 
complex, recruit downstream LC3 conjugation system involving ATG7, ATG12–ATG5-ATG16L1. Once 
conjugated with LC3, phagosomes/ endosomes fuse with LAMP positive lysosomes for cargo 
degradation. Figure taken from (50). 
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inactivate the UVRAG complex which conjugates LC3 to PE in pre-existing single membraned 
compartments (62). In these mice, the ULK1 complex (ULK1-ATG13-ATG101-FIP200) functions 
normally allowing them to activate autophagy.  When challenged with apoptotic cells, RUBCN-/- 
mice showed active engulfment but defect in clearance of dying apoptotic cells which is consistent 
with the previously reported in vitro study (47, 62). As a result to this, high serum levels of pro-
inflammatory cytokines but not anti-inflammatory interleukin 10 (IL10) were detected supporting 
earlier in vitro data (47, 62). Similar observation was made when spontaneous serum levels of pro-
inflammatory cytokines and IL10 was analysed in aged (52 weeks) LAP-/- (rubcn-/-, nox2-/-) mice (62). 
Upon multiple injection of dying cells for over a period of 8 weeks, these mice (starting age 6 weeks) 
showed high levels of anti-nuclear antibodies and anti-dsDNA autoantibodies (62). These animals 
also displayed IgG and C1q deposition in the kidney glomeruli closely resembling to an autoimmune 
disease called systemic lupus erythematosus (SLE) (62). One problem for using the rubcn-/- mouse for 
infection studies is that Rubicon has functions outside its role during LAP.  Rubicon binds NOX2, 
p22PHOX and facilitates ROS production and also modulates pro-inflammatory cytokine signalling 
via NFkB.  Defects in pathogen handling ‘in vivo’ may therefore arise because of altered ROS 
production and cytokine signalling rather than defects in phagocytosis and fusion with lysosomes 
(63-65). 
Overall these results suggested the possible roles of LAP in removal of pathogens, clearance of dead 
cells, suppression of pro-inflammatory cytokines and production of anti-inflammatory interleukin 10 
(IL10) in myeloid cells but could not reveal if the same holds true in non-myeloid cells. Therefore, an 
in vivo model with systemic loss of LAP, but intact autophagy, is required to address this question. 
 
1.3 The WD domain of ATG16L1 is required for non-canonical autophagy.   
ATG16L1 is a mammalian ortholog of the yeast Atg16 protein. In yeast, the protein is made up of two 
domains: N-terminal ATG5 binding domain and a C-terminal coiled coil domain (CCD) (Figure 7A).  
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Figure 7: Evolution of ATG16L1 WD domain: A. ATG16 of the lower eukaryote yeast doesn’t have a 
WD domain but does have an ATG5 binding domain and coiled coil domain (CCD) sufficient to 
activate autophagy. The remaining signalling in yeast is same as higher eukaryotes where VPS34 
mediated PI3P generation facilitates WIPI2 binding which interacts with CCD of ATG16L1. B. Higher 
eukaryotes like mammals evolved a WD domain at the C terminus of ATG16L1. C. The WD domain 
forms a circular 7 bladed β barrel like structure (66). 
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As the name suggests, the N terminal domain binds ATG5 which is coupled covalently to ATG12 
(Figure7A). The C terminal CCD interacts with WIPI2 which brings the ATG12–ATG5-ATG16 complex 
close to membranes of autophagosomes allowing LC3 conjugation to PE (Figures7A). CCD also 
participates in the homo-oligomerisation of ATG16L1which aids in complex formation. Higher 
eukaryotes have evolved an addition N-terminal stretch of 40 tryptophan-aspartic acid repeats 
called the WD repeat domain which is joined to the CCD via a short linker region 
(Figure7B).Crystallisation studies have shown that the 7 WD repeat domains are folded together to 
form a circular β propeller (Figure 7C) (66). The shorter version of Atg16 in yeast forms an active 
Atg12–Atg5-Atg16 complex which is sufficient for autophagy (Figure 7A).  Similarly, expression of the 
N-terminal ATG5 binding and coiled coil domains of ATG16L1 in atg16L1-/-mammalian cells 
reconstitutes autophagy (67).  Although WD domain constitutes a significant portion of ATG16L1 
protein, its cellular role remained uncertain for a long time. A recent collaboration between our lab 
and Oliver Florey at the Babraham Institute, Cambridge, UK showed that WD domain is required for 
non-canonical autophagy like pathway/LAP (67).  
This study by Fletcher et al was conducted by reconstitution of various domain combinations of 
ATG16L1, in vitro, to find out the role of WD domain. Full length (FL), ΔFBD (missing 219-242 
residues required for WIPI2 and FIP200 binding) and ΔWD (missing WD domain) versions of ATG16L1 
were expressed in various atg16L1-/-cell lines which restored canonical autophagy in cells with FL and 
ΔWD ATG16L1 (67). Monensin is an ionophore which induces LC3-II formation by raising lysosomal 
pH causing blockage of canonical autophagy flux. Monensin also causes osmotic imbalance of 
endolysosomal compartments targeting them for non-canonical LC3 lipidation. Monensin induced 
LC3 lipidation on membranes of endolysosomes, phagosomes with apoptotic corpse and LAMP1-
positive bead containing phagosomes was found intact in cells with FL or ΔFBD versions but not in 
ΔWD ATG16L1 expressing cells. Further experiments using agents inducing non-canonical LC3 
lipidation like NH4Cl and Helicobacter pylori secreted virulence factor VacA showed similar results. 
Further analysis of FL or ΔWD ATG16L1 immunoprecipitates from cells, via western blotting and 
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mass spectrometry confirmed the presence of ATG12–ATG5-ATG16L1 complex. Point mutation 
based experiments demonstrated F467 and K490 as key residues of WD domain required for non-
canonical LC3 recruitment. Expression of only WD domain in atg16L1-/-cell lines didn’t recover 
canonical autophagy or non-canonical LC3 conjugation on membranes confirming that WD domain is 
required but not sufficient for non-canonical LC3 lipidation on membranes. In further set of 
experiments this study showed more physiologically relevant evidence where lack of WD domain 
lead to defect in E-α peptide (an exogenous antigen) mediated antigen presentation on MHC class II 
molecules of macrophages and dendritic cells. In later experiments, the ΔWD cells failed to activate 
LC3-II formation following influenza-A infection. Overall, it was shown for the first time that WD 
domain of ATG16L1 is essential to activate non-canonical LC3 lipidation but dispensable for 
canonical autophagy (67). 
1.4 Rationale for deleting WD domain in mice: Deletion of the WD domain of ATG16L1 can be used 
to generate mice deficient in non-canonical autophagy/LAP.  Maryam Arasteh, a PhD student in the 
lab had introduced stop codons into the Atg16l1 gene (Maryam Arasteh, PhD thesis, 2012) to 
engineer mice expressing ATG16L1lacking the WD domain (delta WD mice) (Figure 8A-D). These 
mice were designed by taking account of the amino acids required in the CCD of ATG16L1 to bind 
WIPI2 (Figure8A-D-C) (42).  Two consecutive stop codons were inserted after CCD to terminate the 
translation of linker region and WD domain but preserve glutamate residues at 226 and 230 
positions in CCD that are required for WIPI2 binding (Figure 9A-D).  These mice are described in 
more detail in chapter 3.  
Homeostasis is the property of cells, tissues and organisms to maintain a constant and continuous 
levels of various essential biochemical and physiological processes against different environmental 
stimuli like change in nutrients, invasion of pathogens etc. As LAP is a part of innate immune 
pathway to protect different tissues against pathogen infection and hence contributing in keeping 
up homeostasis, this thesis describes the characterisation of delta WD mice to determine if they can 
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maintain tissue homeostasis in absence of non-canonical autophagy/LAP. If they can, these mice will 
provide a novel model for studying the role played by non-canonical autophagy during infection ‘in 
vivo’. 
1.5 Specific aims: The specific aims of study presented in this thesis are: 
1. To investigate the expression of WD deficient version of ATG16L1 protein in cells and tissues of 
E230 and E226 mice 
2. To investigate the activity status of autophagy and LAP in cells and tissue of E230 and E226 mice 
3. To analyse the status of homeostasis in various non-immune tissues of E230 and E226 mice 
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Figure 8: Deletion of WD domain of ATG16L1: A. The representative exon map of Atg16l1gene 
shows the exon 6 which was engineered to remove WD domain. B. The magnified view of exon 6 
(representative) highlighting the regions on the gene, specific for glutamate residues at 226 (E226, 
yellow) and 230 (E230, green) positions on CCD. In atg16l1E230mice, two stop codons (red circles) 
were introduced after sequences corresponding to glutamate 230 to remove the WD domain. In 
atg16l1E226 mice the stop codons got placed after glutamate 226 sequences removing glutamate 230 
sequences. Part of targeting vector sequences (black region) was inserted along with the stop 
codons near exon 6. C. The c-DNA sequencing results showing peaks along with corresponding 
amino acid sequences highlighting positions of glutamate residues (E) and stop codons in the 
genomic DNAs from control, E230 and E226 mice. D. The representative domain diagram of full 
length, E230 and E226 versions of ATG16L1 protein, indicating role of E230 and E226 residues in 
WIPI2 binding. The WIPI2 binds to full length and E230 version of ATG16L1 through glutamate 226 
and 230 but not with E226 version because of loss of glutamate 230.         
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Chapter-2 
Materials and methods 
2.1Genotyping:  
2.1.1 Reagents: Tris base (Fisher Scientific, BP152-1), HCl (Fisher Scientific, H/1200/PB08), EDTA 
(Fisher Scientific, BP120-500), Acetic acid (Fisher Scientific, A/0360/PB17), SDS (Fisher Scientific, 
BP166-500), NaCl (Fisher Scientific, S/3160/60), Proteinase-K (non-commercial), Sterile water (Fisher 
Scientific, BP2484-100), dNTPs(Bioline, BIO-39025), Oligonucleotide primers (Sigma Aldrich), 10X 
Dream Taq Buffer (with MgCl2) with Dream Taq DNA polymerase (500U, 5U/µl, Thermo Scientific, 
REF EP0702), Agarose (Bioline, BIO-41025),Glycerol (Fisher Scientific, 10795711), Orange G (Sigma, 
O3756), Ethidium bromide (Fisher Scientific, E/P800/03) 
2.1.2 Polymerase chain reaction (PCR): Mice ear biopsies were digested in lysis buffer (100 mM Tris-
HCl pH 8.5, 5 mM EDTA pH 8.0, 0.2% SDS, 200 mM NaCl, 100µg/ml Proteinase K and sterile water) 
overnight at 55°C. Lysed biopsies were diluted 1:20 in distilled water before being used as template 
for the PCR using specific oligo-nucleotide primers (Table 1B). The PCR mix was prepared (Table 1A), 
and PCR program (Table 1C) was executed for (~2 hours) using thermos-cycler (Applied biosystems, 
Veriti 96 well). PCR products were stored at 4°C until further step.  
Table 1: Genotyping PCR details: 
(A). PCR mixture recipe: 
 
dNTP mix = 0.5 µl (250 µM) 
Dream Taq Buffer (10X with MgCl2) = 5.0 µl (1X) 
Forward & reverse primer mix = 1.0 µl (20pM) 
Dream Taq DNA polymerase = 0.25 µl  
(B). Sequence of primers used: 
 
290 (forward): CAAATATGCCTTCAGAACTG   
291 (reverse) :GCTGTAGTTCCAATCCCTAA 
338 (reverse) :TCGATGCTAGCCTACTATTC 
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Biopsy lysate (1:10 diluted) = 3 µl 
Water = 40.25 µl  
Total = 50.0 µl 
(C). PCR program used: Touchdown PCR (Annealing temperature decreases from 65°C to 56°C at 
the rate of 1°C/cycle) 
 
95°C – 10 minutes 
95°C – 45 seconds 
65°C – 1min (decreases 1°C/ cycle) 
72°C – 1 minute 
95°C – 45 seconds 
55°C – 1 minute 
72°C – 1 minute 
72°C – 10 minutes 
04°C – forever (hold) 
 
2.1.3 Agarose gel electrophoresis: The agarose gels were casted by boiling 1% agarose solution (in 
TAE buffer) and then cooled down to room temperature after poring it in a casting tray with the 
combs to create wells. Gels were submerged in electrophoresis tank filled with TAE buffer. The 
genotyping PCR products were mixed with 5X orange coloured DNA loading dye (50% Glycerol + 1X 
TAE buffer + 0.25g Orange G dye + distilled water) (1:5) and appropriate amount of the mixture was 
loaded in the wells of agarose gels. For every gel, one well was loaded with standard DNA size 
markers to facilitate size determination. Samples were subjected to electrophoresis by applying 
electricity at constant 250 volts for 40minutes. Gels was then stained in staining buffer (TAE buffer 
with 0.1% Ethidium bromide) for 30 minutes and visualised using gel documentation system fitted 
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with UV light source and camera. Genotypes were defined based on expected amplicon sizes as 
shown in the table below. 
Table 2: Expected results of PCR and annotation of genotypes:   
Strain Primer pair used Genotype Expected amplicon size 
 
 
              E230 
 
 
290 & 291 
Wild Type (+/+) 291 bp 
Heterozygous (+/-) 291 bp& 639 bp 
Mutant (-/-) 639 bp 
 
290 & 338 
Wild Type (+/+) No amplification 
Heterozygous (+/-) 179 bp 
Mutant (-/-) 179 bp 
 
 
             E226 
 
290 & 291 
Wild Type (+/+) 291 bp 
Heterozygous (+/-) 291 bp& 639 bp 
Mutant (-/-) 639 bp 
 
290 & 338 
Wild Type (+/+)  
No amplification Heterozygous (+/-) 
Mutant (-/-) 
 
2.2 Isolation and culture of primary cells: 
2.2.1 Reagents: DMEM(ThermoFisher scientific, Gibco, 11570586), FBS (ThermoFisher scientific, 
Gibco, 10500-064), Penicillin-streptomycin (ThermoFisher scientific, Gibco, 15140-122),Trypsin 
(ThermoFisher scientific, Gibco, 25200-072), Cell strainers (40µm, ThermoFisher scientific, 
22363547), Ethanol (VWR, 20821.330), RPMI (ThermoFisher scientific, Gibco, 61870-010), M-CSF 
(Peprotech, 315-02-100 G) 
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2.2.2 Mouse embryonic fibroblasts (MEFs): To make MEFs, 13.5 days pregnant females were 
sacrificed and the embryos were dissected out. After removing the liver, heart and head, rest of 
the body of embryos were cut into small pieces and submerged in DMEM media. A small tail 
piece from all the embryos were frozen to confirm genotypes later. These embryos were further 
digested for 30-60 minutes at 37°C by adding trypsin in the suspension. Once a fine suspension 
was ready, it was passed through cell strainers to filter out tissue chunks. The cells were then 
grown in growth media (DMEM+10% FBS+1% Penicillin-streptomycin) till confluent. The MEF 
culture from embryos of required genotypes (e.g. E230, E226 and littermate controls) were 
continued and rest (e.g. heterozygous for E230 and E226) were frozen. 
2.2.3 Mouse skin fibroblasts: Small shaved area of mice skin were cut in to small pieces, washed 
with 70% ethanol and then grown in growth media (DMEM+10% FBS+1% Penicillin-
streptomycin) in a 24 well plate. Skin fibroblasts were gradually migrated from tissue to the 
plate within 7 days. The cells continued to grow for 1-2 weeks. 
2.2.4 Mouse bone marrow derived macrophages (BMDMs): Femur bone form mice legs were 
dissected out and attached muscle, ligaments and tendons were cleaned off. The bone marrow 
cells were flushed out by passing RPMI media through bone. Those cells were filtered through 
cell strainer and collected in 15 ml tubes. Cells were pelleted down by centrifugation at 1000 
rpm for 5 minutes. Cell pellets were re-suspended in growth media (RPMI +10% FBS+1% 
Penicillin-streptomycin), seeded on 100 mm tissue culture dishes and cultured in presence of 
growth factor M-CSF (50ng/ml) for 72 hours.  After this the cells were washed and re-
supplemented with growth media with M-CSF and cultured for further 72 hours. 
2.3LC3-associated phagocytosis (LAP) assay: 
2.3.1 Reagents: Carboxyl-modified beads (Polybead carboxylate 3.0 µm, Bangs Laboratories, 
09850), Pam3csk4 (Invivogen, TLRL-PMS),MES free acid (Sigma, M8250), NaOH (Fisher Scientific, 
S/4920/53), EDC (Sigma), PBS (Oxoid, BR0014G), Tween-20 (Sigma, P1379), EDAC/ WSC (Sigma), 
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Glycine (Fisher Scientific, BP38-1), Blocking molecules, Methanol (VWR, 20847.320), Goat serum 
(ThermoFisher Scientific, Gibco, 16210-072), Triton X-100 (Sigma, T8787), Anti LC3 A/B antibody 
(Cell Signalling Technologies, 4108), Anti Rabbit secondary antibody (Alexa 488, Invitrogen, 
A11008), DAPI (Thermo Scientific, 62248), BSA (EUROPA, EQBAH62-1000), Fluoromount-G 
(SouthernBiotech, 0100-01) 
2.3.2 Coating of beads: Carboxyl polystyrene particles (beads) were coated with Pam3csk4 by 
via following steps (Bangs Laboratories, Inc. Tech Note 205, III). 
2.3.3 Preparation of beads: 2.5x106 beads were added to 62 μl of 0.1M MES buffer (aqueous 
solution of MES free acid with pH adjusted to 5.7 – 7.2 via HCl/ NaOH).  
2.3.4 Preparation of coating: 5 nano moles of amino modified oligonucleotide were added to 25 
μl of 0.1M MES buffer followed by 0.3 mg of EDC (1-ethyl-3(-3-dimethylaminopropyl) 
carbodiimide hydrochloride) and then vortexed before incubation for 20 minutes at room 
temperature. This step (0.3 mg EDC addition, vortexing and incubation) was repeated thrice and 
a final incubation at room temperature was given for 80 minutes on a rotary mixer. Mixture was 
centrifuged and the pellet was re-suspended in 1 mL of 0.1M PBS containing 0.02% Tween-20. 
Once again the mixture was centrifuged and pellet was re-suspended in 150 μl of TE buffer (10 
mM Tis, pH 8.0 + 1 mM EDTA, pH 8.0 + distilled water). Finally this mixture was again subjected 
to centrifugation followed by pellet re-suspension in 200 μl of TE or IBS and stored at 4°C until 
further use. 
2.3.5 Coating process: 40μl of beads (25mg/ml) were washed (mixed and centrifuged) twice in 
1ml of activation buffer (MES) and the pellet was re-suspended in 100μl of activation buffer 
(MES), ensuring that the beads are well suspended (by vortexing). This made the bead 
suspension dilute to 10 mg/ml. While mixing, 1mg of Water soluble carbodiimide (WSC) was 
added and allowed to react for 15 minutes at room temperature (18-25˚C). Beads were washed 
twice (mixed and centrifuged) in and then re-suspend in 50μl of coupling buffer (PBS) with 
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continuous mixing to keep them well suspended. The coating preparation (1-10X excess of 
calculated monolayer) was mixed with 50μl of coupling buffer, combined with bead suspension 
and allowed to react at room temperature for 2-4 hours with constant mixing. Coated beads 
were washed and re-suspended in 100μl of quenching solution (30-40 mM Glycine + 0.05-1% 
w/v Blocking molecules) while mixing gently for30 minutes. Beads were finally washed and re-
suspended in storage buffer (0.01-0.1% w/v blocking molecule, pH 7.0-7.5) to desired storage 
concentration (10 mg/ml). These coated beads were stored at 4˚C until used.  
2.3.6 Assay: Actively growing BMDMs on cover glasses (in RPMI +10% FBS+1% Penicillin-
streptomycin) were fed with coated beads at a ratio of 1:10 (cell: bead) for 90 minutes. After 
incubation, media was removed, cells were washed with PBS and fixed by adding chilled 
methanol and incubating at -20°C for 7 minutes. Cells were washed with PBS and then 
permeabilized and blocked simultaneously by incubating for 30 minutes (with slow rocking) in 
blocking cum permeabilization buffer (5% Goat serum + 0.3% Triton X-100+ PBS). Cells were 
probed with appropriately diluted (dilution buffer = 1% BSA + 0.3% Triton X-100 + PBS) anti LC3 
antibody (Rabbit, polyclonal) at 4°C overnight. Next day, the cells were washed with PBS, 
incubated with secondary antibody (Anti rabbit, green fluorescent) for 2 hours at room 
temperature (protected from light). The cells were washed with PBS, stained with DAPI (diluted 
1:5000 in PBS) for 5 minutes at room temperature and washed again to remove excess DAPI. 
Finally the cover glasses (with attached cells) were mounted on glass slides using mounting 
media (Fluoromount-G). The cells were observed under fluorescent microscope for LC3 
associated phagosomes containing beads. 
2.4 Autophagy assay: 
2.4.1 Reagents: HBSS (ThermoFisher scientific, Gibco, 14025-050),   
2.4.2 Assay: Approximately 2X106 cells (e.g. MEFs or skin fibroblast) were grown on cover glasses 
in 24 well tissue culture plates. Once the cells were fully attached on cover glasses, the 
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unattached cells were washed out by PBS and cells were further grown in either growth media 
(DMEM/ RPMI +10% FBS+1% Penicillin-streptomycin) or starvation media (HBSS) for 2 hours. 
After incubation, cells were washed, fixed and processes as mentioned in the previous section 
(LAP assay). Cells were observed under fluorescent microscope for active autophagy as LC3 
puncta (autophagosomes). 
2.5 Fluorescent microscopy: Mounted cells (e.g. BMDMs, MEFs or skin fibroblasts) were 
observed for green and blue fluorescence. Fluorophores were excited with appropriate light 
source and emitted signal were observed under 63X objective followed by photographing 
through the mounted camera. 
2.6 Western blotting: Based on the downstream application, western blotting was done in 
following three ways: 
2.6.1 Reagents: M-PER (ThermoFisher Scientific, 78501), Protease inhibitor cocktail (Sigma, 
Roche, 04693159001), BCA assay kit (ThermoFisher Scientific, 23225), Precast SDS-PAGE gels 
(RunBlue 4-12%Bis-Tris gels, Expedeon, NBT41212), PVDF membrane (Immobilon, Millipore, 
IPFL00010), Skimmed milk (Oxoid, LP0031), Anti ATG16L antibody (MBL, M150-3), Anti p62/ 
SQSTM1 (Abcam, ab91526), Anti β actin/ ACTB antibody (Sigma, A5441), IRDye labelled 
secondary antibodies (LI-COR biosciences, 926-32211, 926-68020), Sodium deoxycholate [Sigma, 
D-5670], Protease inhibitor (Sigma, P8340), Phosphatase inhibitors (Sigma, P5726),anti GAPDH 
antibody (Abcam, ab9482), Nitrocellulose membranes (Bio-Rad, 1620115), Supersignal West Pico 
chemiluminescent substrate (ThermoFisher Scientific, 34080). 
2.6.2 Cell western blotting:  Approximately 2X106 cells were washed with PBS, detached by 
scrapping in 100μl of lysis buffer (M-PER + protease inhibitor cocktail), re-suspended and 
incubated on ice for 30 minutes. The lysates were centrifuged at 16000Xg (at 4°C) and 
supernatants were transferred to fresh tubes. Total proteins were quantified by BCA assay kit. 
Equal amount of protein was loaded in the wells of precast SDS-PAGE gels and electrophoresed 
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at 150 volts for nearly 2 hours. Separated proteins were transferred to PVDF membrane by 
standard wet transfer protocol and apparatus. After transfer, membranes were incubated in 
blocking buffer (5% skimmed milk in 1X TBS [50mM Tris (pH 7.5) + 150mM NaCl]) for 1 hour at 
room temperature followed by probing with appropriately diluted (in blocking buffer) primary 
antibodies (Anti ATG16L, Anti LC3 A/B, Anti p62/ SQSTM1 and Anti β actin antibodies) (at 4°C for 
overnight). Next day, the blots were washed thrice, for 15 minutes each, in wash buffer (1X TBS 
+ 0.5% Tween 20) and probed with 1:10000 diluted secondary antibodies (IRDye labelled) (at 
room temperature for two hour, protected from light). After one hour, the blots were again 
washed thrice, as before, and the signals were (visualized and imaged) using the Odyssey 
infrared system (LI-COR). 
2.6.3 Tissue western blotting: Mice were dissected to harvest organs (e.g. livers, kidneys 
muscles and brains). Organs were snap frozen in liquid nitrogen and stored in -80°C freezer until 
further used. Using a clean and chilled mortar, pestle and liquid nitrogen, frozen organs were 
crushed into fine powder. Appropriate amount of crushed organs were suspended and lysed in 
RIPA buffer (150 mM NaCl + 1% TritonX-100 + 0.5% Sodium deoxycholate + 0.1% SDS + 50 mM 
Tris, pH 8.0 + protease and phosphatase inhibitors) by incubating on ice for 30 minutes, further 
homogenisation and subjecting to freeze thaw cycles. Lysates were briefly sonicated followed by 
centrifugation at 16000Xg to transfer supernatants into fresh tubes. Total proteins were 
quantified (BCA assay kit), resolved on SDS gels (4-12% Bis-Tris gels), transferred to nitrocellulose 
membranes and probed with  appropriate primary (Anti ATG16L, Anti LC3 A/B, Anti p62/ 
SQSTM1 and anti GAPDH antibodies) and secondary antibodies (1:5000 of Anti-mouse HRP or 
anti-rabbit HRP) as mentioned above. The signal was developed via exposure to 
chemiluminescent HRP substrates (Supersignal West Pico) and imaged by Chemidoc XR system 
(BioRad). Images were quantified via Image J (NIH, USA) and plotted by using GraphPad Prism 7. 
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2.7 Growth rate measurements: Mice were weighed every week (from 3rd to 9th week post 
birth). Growth rates were measured by plotting body weights (g) on Y axis and time (weeks) on X 
axis using GraphPad Prism 7.   
2.8 Fertility assessment: Mice breeding pairs were continuously monitored for recording the 
number of pups born along with their genotypes. 
2.9 Morphological analysis of different tissues: Whole bodies and dissected tissues from control 
and mutant mice were photographed and weighed. Tissue weights (g) and the percentage of 
ratio of tissue to whole body were plotted as columns using GraphPad Prism7.  
2.10 Tissue preservation and processing:  
2.10.1 Reagents: NBF (Sigma, HT501128),  
2.10.2 Process: Dissected tissues were fixed by submerging in 10% neutral buffered formalin 
(NBF) for overnight at room temperature. Next day, the tissues were transferred to 70 % ethanol 
and stored at room temperature until further processing. Tissues were later subjected to 
overnight dehydration in an automatic tissue processor (Leica, ASP 300S). Next day, those 
dehydrated tissues were submerged and stored in molten paraffin wax (Paraplast, Sigma, P3558) 
till embedding station (Leica, EG1150) was ready to be used. Tissues were, one by one, 
embedded in paraffin wax by placing them in correct orientation on top of a partially solidifies 
thin paraffin layer inside a metal or plastic mould. Once the tissue was set on its position, rest of 
the volume of mould was filled with molten paraffin wax and allowed to cool down by putting on 
top of precooled platform. This process generated solid cuboidal tissue blocks for long term 
tissue preservation. These formalin fixed paraffin embedded (FFPE) tissue blocks were stored at 
room temperature before making 5µ thick sections using microtome (Microm, HM355S). 
Tissue sections were generated by first cooling the tissue blocks for easy cutting. The cooled 
blocks were fixed on the holder and several 5µ thick sections were sliced out using microtome 
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(Microm, HM355S). Those thin sections were overlaid on top of warm water (42°C) to flatten 
them. These sections were then carefully transferred on glass slides (Thermo Fisher Scientific, 
Superfrost plus, J1800AMNZ) and left to stick and dry overnight at room temperature. These 
sections were labelled and stored for further staining procedures like H & E staining or 
immunostaining. 
2.11 Haematoxylin and Eosin (H & E) staining of tissue sections:  
2.11.1 Reagents: Histoclear (National diagnostics), Harris hematoxylin (Sigma, HHS128), Sodium 
bicarbonate (ThermoFisher Scientific, S/4240/53), Eosine (Sigma, HT110116), DPX mounting 
medium (ThermoFisher Scientific, D/5319/05).  
2.11.1 Process: Above tissue sections were H & E stained by passing them through different 
solutions as indicated in table 3: 
Table 3: Hematoxylin-eosin staining procedure of formalin fixed paraffin embedded tissue 
sections: 
Step no. Solution Time 
1 Histoclear solution-I 5 minutes 
2 Histoclear solution -II 5 minutes 
3 100% Ethanol 2 minutes 
4 80% Ethanol 2 minutes 
5 70% Ethanol 2 minutes 
6 Rinsing under running tap water 5 minutes 
7 Hematoxylin solution 2 minutes 
8 Washing under running tap water 5 minutes 
9 1% HCl in 70% Ethanol  15 seconds 
10 Rinsing in water ~10 seconds 
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11 0.1% Sodium bicarbonate solution 1 minute 
12 Washing under running tap water 5 minutes 
13 Eosin solution 30 seconds 
14 70% Ethanol  2 minutes 
15 80% Ethanol 2 minutes 
16 100% Ethanol 2 minutes 
17 Histoclear solution -II 5 minutes 
18 Histoclear solution –I  5 minutes 
 
Sections were then mounted using cover glasses and mounting media (DPX) followed by 
overnight drying at room temperature. Those sections were observed under bright field 
microscope. 
2.12 Immunostaining of tissue sections:  
2.12.1 Reagents: Tri Sodium Citrate di hydrate (Fisher Scientific, S/3320/53), Citric acid (Fisher 
Scientific, S/6200/53), Hydrogen peroxide (Sigma, 216763), Antibody dilution buffer (Dako, 
K3468), Chromogen buffer (Dako, K3468), anti MKI67/Ki67 antibody (Abcam, ab66155), anti 
ITGAM/Cd11b antibody (Abcam, ab133357), Anti rabbit-HRP (Dako, K4003),  
2.12.2 Process: Tissue sections (after sectioning and drying) were first de-paraffinised and 
rehydrated by following steps 1-6 of table 3. Antigen retrieval was performed by microwaving 
(600 watts) the sections in antigen retrieval buffer (~0.053% w/v Tri Sodium Citrate di hydrate + 
0.17% w/v Citric acid + distilled water), twice for 10 minutes each, with replenishment of lost 
buffer. Sections were left in the antigen retrieval buffer to cool down at room tempera before 
washing them in PBS (thrice for 3 minutes each). Sections were incubated for 10 minutes at 
room temperature in 10% (v/v) hydrogen peroxide (H2O2) solution in methanol (CH3OH) to block 
active peroxidases followed by washing in PBS as before. Non-specific binding site were blocked 
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by incubation in blocking buffer (10% v/v Goat serum + 0.3% v/v Triton X-100 + PBS) for 1 hour 
at room temperature before overnight probing with primary antibody (diluted in antibody 
dilution buffer) (anti SQSTM1/p62 antibody, anti MKI67/Ki67 antibody, anti ITGAM/Cd11b 
antibody) at 4°C. Next day, tissue sections were washed in PBS (as before), probed with 
appropriate secondary antibody (diluted in antibody dilution buffer) (anti rabbit-HRP; Dako, 
K4003) for 1 hour at room temperature, washed again and developed by adding chromogen 
buffer (2% v/v Chromogen + Substrate buffer). Once sufficient signal was observed under 
microscope, the reaction was stopped by submerging the sections in PBS. Finally sections were 
counter stained by following steps 6-18 (H & E staining) and avoiding step 13. Sections were then 
mounted using cover glasses and mounting media (DPX) followed by overnight drying at room 
temperature. Next day those sections were observed under bright field microscope (Axioplan 2, 
Zeiss, fitted with coloured Axio Cam HRc camera). 
2.13 Liver enzyme assay:  
2.13.1 Reagents: ALT/ GPT assay kit (Roche),  
2.13.2 Process: Levels of Alanine amino transferase (ALT) also known as Glutamate pyruvate 
transaminase (GPT) in mice blood serum were measured as a marker for liver damage. Mice 
were killed by cervical dislocation and their hearts were punctured to collect blood through a 
sterile 1 ml needleless syringe. Collected blood samples were left at room temperature for 30 
minutes to clot followed by centrifugation at 3000 rpm for 10 minutes. Supernatants (serums) 
were transferred to fresh tubes, snap frozen in liquid nitrogen and then stored in -80°C freezer 
for later use. At the time of assay, serums were thawed on ice, appropriately diluted and 
transferred to 2ml assay tubes along with enzyme substrate standards. The assay tubes were 
placed in respective slots of the automatic reader and the appropriate program was executed. 
The machine automatically prepared serial dilution of substrate standards to generate a 
standard curve. The software then used the standard curve to calculate and display final 
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concentration of ALT (units/ml) in serum samples. The data was plotted and compared using 
GraphPad Prism7. 
2.14 Gel filtration chromatography:  
2.14.1 Reagents: ENrichTM SEC 650 (Bio-Rad, 780-1650), Blue dextran (Sigma, D4772-1VL), 
protein standards (Sigma, MWGF1000), Anti ATG5 antibody (Abcam, ab108327), Anti WIPI2 
antibody (Abcam, ab101985).  
2.14.2 Process: Freshly dissected liver and brain tissues were Dounce homogenised in chilled 
PBS (supplemented with protease inhibitor cocktail). Tissue homogenates were clarified by first 
spinning at 100Xg (4°C) for 5 minutes (no pallet) and then 13000Xg (4°C) for 20 minutes. The 
supernatants were used to separate cytoplasmic fractions by spinning at 100,000Xg at 4°C for 1 
hour. Obtained supernatants (cytoplasmic fractions) were then loaded on a gel filtration column 
(ENrichTM SEC 650) to purify (AKTA purifier, GE Healthcare) protein complexes of different sizes 
collected as various eluted fractions. Those fractions were then analysed for the presence of 
ATG16L1, ATG5 and WIPI2 proteins via SDS-PAGE and western blotting. For size determination of 
protein complexes, the void volume (V0) of the column and elution volume (Ve) of known protein 
standards were obtained by sequentially passing blue dextran and mixture of protein standard 
through the column. A standard curve was generated by plotting the ratios (Ve/V0) on X axis and 
log of molecular masses on Y axis. Size of different protein complexes were extrapolated through 
the standard curve. 
2.15 Cytokine assay:  
2.15.1 Reagents: ProcartaPlexTM Simplex Immunoassay kits (ThemoFisher Scientific, EPX01A-
26015-901, EPX01A-20603-901, EPX01A-26004-901, EPX01A-26005-901, EPX01A-20607-901 and 
EPX01A-26002-901).  
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Serums from young(2-3 months old) and aged(5-6 months old) mice were used to measure 
cytokine levels using various Luminex kits (ProcartaPlexTM Simplex Immunoassay kits)by 
following manufacturer’s instructions: 
2.15.2 Standard preparation: Based on antigens of interest, various lyophilised specific antigen 
standards were first reconstituted in 1X universal assay buffer and then combined appropriately 
to a final volume of 250µl. Standards were serially diluted up to 4 folds using 1X universal assay 
buffer and stored on ice until used.  
2.15.3 Magnetic bead preparation: According to the need of specific antibodies, a(1X) 5ml pool 
of magnetic beads was prepared by combining 100µl each from various (50X) suspensions of 
beads coated with capture antibodies against specific antigens, in 1X wash buffer. The mixture 
was stored on ice until used. 
2.15.4 Detection antibody preparation: As per use of capture antibodies (on beads), a pool of 
different detection antibodies was prepared by diluting 50X stocks (of each) in antibody diluent 
to a final volume of 3 ml (1X). 
2.15.5 Assay: The assay plate was secured on the hand-held magnetic plate holder and 
appropriate amount of magnetic bead mixture was added in each well. Beads were allowed to 
accumulate at the bottom of wells for 2 minutes and then the liquid was removed by inverting 
the plate (with magnetic holder) on a paper towel. Beads were washed in 150µl (1X) wash buffer 
in the similar fashion.  In each designated well 25µl of (1X) universal assay buffer and 25µl of 
corresponding antigen standard or sample (serum) was added. The wells dedicated for blanks 
were filled with 25µl of (1X) universal assay buffer. The plate was sealed, covered and incubated 
with shaking at 500 rpm for overnight at 4°C. Next day the plate was further incubated, with 
shaking at 500 rpm for 30 minutes at room temperature before washing three times as before. 
25µl of 1X detection antibody mixture was added in each well followed by sealing, covering and 
incubation (500 rpm) for 30 minutes at room temperature. Wells were washed thrice as earlier 
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before adding 50µl of SAPE in each well. Again the plate was sealed, covered and incubated (500 
rpm) at room temperature for 30 minutes. After washing thrice, 120µl of reading buffer was 
added in each well and the plate was sealed, covered and incubated for 5 minutes (500 rpm) at 
room temperature. Plate was read on Luminex instrument (LuminexTM100/200TM), obtained data 
was plotted and analysed using GraphPad Prism7. 
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Chapter-3 
Analysis of canonical and non-canonical autophagy in mice lacking the WD 
domain of ATG16L1 
3.1 Generation of mice: Unlike yeast, the ATG16L1 protein of higher eukaryotes including 
mammals carries a C-terminal WD40 domain (Figure 7A & B). As published earlier  WD40 domain is 
reported to play a  role in non-canonical autophagy ‘in vitro’(67). To extend this finding mouse 
models lacking the WD40 domain of ATG16L1 (ΔWD) were generated by Maryam Arasteh, a PhD 
student in the lab(Julia Maryam Arasteh, PhD thesis, 2012) (Figure 8A-D).These mice were made by 
introducing two stop codons at the end of coiled coil domain (CCD) to preserve the glutamate 
residues at 226 (E226) and 230 positions (E230) in CCD of ATG16L1 as they are required for its 
interaction with WIPI2 protein to activate autophagy (42) (Figure9A-D).   
The exact location of coiled coil domain (CCD) on the Atg16l1gene was already worked out in yeast 
homologue which was later shown to be conserved in mice (68, 69). The stop codons were 
introduced into exon 6 to ensure its presence in all the four alternate spliced forms of Atg16l1 
(Figures9A&B).The final targeting vector containing the neomycin resistance gene, bovine growth 
hormone polyadenylation site (bGH-pA) and frt sequences was transfected into mouse embryonic 
stem (ES) cells and the positive cells were selected based on neomycin resistance (Figure 10A).  The 
ES cell clones that had undergone correct homologous recombination (Figure 10A) were selected via 
southern blotting and PCR. These cells were injected into blastocyst and transplanted in to a 
surrogate mouse mother.  
The chimeras delivered by the surrogate mother were confirmed for the presence of mutation by 
PCR. These chimeras were crossed with C57BL/6 to confirm the germ line transmission of the 
mutation. Once the mutation was confirmed via PCR in the offspring, they were subjected to further 
crosses with Flp mice and C57BL/6, respectively, to remove neomycin resistance gene and flp gene  
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Figure 9: Key residues of CCD mediate WIPI2 binding: A. The graphical model shows that ATG16L1 is 
made up of an N terminal ATG5 binding domain (ATG5b), a coiled coil domain (CCD), a linker region 
and an N terminal WD domain. The glutamate residues at 226 (E226) and 230 (E230) positions on 
CCD are essential for WIPI2 binding. B. Structural model (taken from ref. 39) of CCD of ATG16L1 
showing important residues required for its interaction with WIPI2. C. Structural model of WIPI2 
(circular β pleated structure) in association with CCD of ATG16L1 (pink coloured α helix) highlighting 
key residues of CCD (E226, E230) and WIPI2 (R125, R108) required for interaction. The WIPI 
structure also shows PI3P binding sites and 7 β blades and β1-β2 loop, a major distinguishing feature 
between WIPI isoforms (taken from ref. 39).   
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Figure 10: Generation of mice deficient in WD domain: A. Exon 6 of Atg16l1 gene was engineered 
to create WD deficient mice. The targeting vector containing upstream and downstream regions of 
homology, engineered exon 6, stop codons, polyadenylation sequence (bGH-pA), frt sites, neomycin 
resistance gene and a thymidine kinase gene (tk) was used for transfection. B. Obtained chimeras 
were crossed with flp mice to remove neomycin gene by flp-frt mediated excision. Further obtained 
mice were crossed with C57BL/6 to remove flp and to obtain pure heterozygous mice. The 
heterozygous mice were crossed together to obtain homozygous mutant mice.   
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sequentially (Figure 10B). The resulting heterozygous mice were crossed to generate homozygous 
mutant mice (Figure 10B). These mice were genotyped via PCR using specific primers (Figure 11A-C). 
3.2 Mouse nomenclature: In generating mice lacking the WD domain, two stop codons were located 
after the E230 residue of ATG16L1 required for the WIPI2 binding sites (Figure9B-D). These mice 
were named ‘E230’ mice. Surprisingly, due to an unexpected recombination event, we also got a 
second population of mice where the stop codons got inserted after the E226 residue causing 
translation termination before E230 residue (Figure9B-D).  These mice were named ‘E226’ mice.  
3.3 Genotyping by PCR: These mice were genotyped by PCR using three primers (290, 291 & 338) 
(Figure 11A-C). The primers 290 and 291 were designed to specifically bind to upstream and 
downstream intronic region of exon 6 (Figure11A). A third primer 338 was designed to bind to the 
vector cassette inserted next to the exon 6. The primer set 290-291 amplified 291 bp fragment in 
case of littermate control mice (+/+) (Figure 11A). In case of E230 and E226 mice, because of 
homologous recombination and insertion of vector sequences with stop codons, the binding site of 
291 got pushed further away from 290 sites (Figure 11A). Therefore, in case of mice with a copy of 
either E230 or E226 version of Atg16l1 gene, the PCR amplified a fragment of 639 bp (Figure 11B & 
C). As expected ear lysates from all the littermate control (or wild type (WT)) mice (+/+) showed a 
single amplicon of 291 bp whereas biopsies from homozygous mutant mice (-/-) showed a single 
amplicon of 639 bp (Figure 11B & C). Heterozygous mice (+/-) with only one copy of mutant gene 
amplified two bands: 291 bp and 639 bp corresponding to wild type and mutant copy of genes 
respectively (Figure 11B & C). A third primer 338 was employed to differentiate between E230 and 
E226 genotypes as it was targeted to bind sequences corresponding to E230 region of exon 6 and 
also to the stop codons on the inserted cassette (Figure 11A). Since the sequences corresponding to 
E230 and stop codons were missing in E226 and littermate control (+/+) lysates, the combination of 
290 and 338 primers gave a single amplification band of 179 bp for E230 mutant (-/-) and 
heterozygous (+/-) mice (Figure 11B).   
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Figure 11: Genotyping of WD deficient mice: A. The representative map of exon 6 in control 
(Atg16l1), E230 (atg16l1E230) and E226 (atg16l1E226) mice genomes is shown along with the 
sequences for glutamate residues at 226 and 230 positions indicated in yellow and green, 
respectively. Stop codons are shown as red circles. The specific binding regions of genotyping 
primers 290, 291 and 338 are indicated. The expected amplification size is indicated against each 
respective primer pair B. Agarose gel picture as a result of genotyping PCR for E230 mice is shown. 
The mutants (-/-) and wild types (WT, +/+), as expected, showed amplification of 639 bp and 291 bp 
respectively whereas heterozygous (+/-) mice showed both the band (639 bp and 291 bp). The 
second gel showed a single band of 179 bp for mutant and heterozygous mice but no bands for WT 
mice which was expected. C. The genotyping PCR results for E226 mice showed similar results, like 
E230 mice, where a band of 291 bp for WT, a band of 639 bp for mutant and both the bands were 
seen in heterozygous mice.      
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3.4 Analysis of expression of truncated ATG16L1 by western blot: Once the genotypes were 
assigned, cells and tissues form these mice were tested for the expression of WD deficient ATG16L1 
via western blotting (Figure 10). 
3.4.1In Mouse embryonic fibroblasts (MEFs): Heterozygous (+/-) E230 mice were crossed together 
and pregnant females were dissected on 13.5-day post mating to harvest embryos. The embryos 
were used to make mouse embryonic fibroblasts (MEFs). Cells were grown in nutrient rich or 
starvation media for 2 hours and then lysed and immunoblotted for ATG16L1. As shown in the figure 
12A, ~66 kDa (both α and βisoforms)bands corresponding to full length ATG16L1 was observed in 
control MEFs but not in E230 and E226 MEFs both in nutrient rich and starvation conditions. The ~66 
kDa band was also missing in lysates of MEFs with full length knock out of Atg16l1 gene (FL KO) 
(Figure 12A).  These results confirmed the absence of full length ATG16L1 in E230 and E226 MEFs 
but couldn’t confirm the stable expression of truncated protein of ~27 kDa. 
3.4.2 In different mice tissues: Further, the expression of truncated version of ATG16L1 was 
examined in different mice tissues (Figure 12B). Mice were dissected to harvest liver, brain and 
gastrocnemius muscle. Lysates from these tissues were immunoblotted for ATG16L1 protein and as 
expected a ~66 kDa band of full length ATG16L1 was seen in all the tissue lysates prepared from 
littermate control mice (Figure 12B). Two bands corresponding to α and β isoforms of ATG16L1 were 
detected in liver and muscle lysates (69). Although the full length band was missing from the tissue 
lysates of E230 mice, a smaller band   of ~27 kDa corresponding to E230 version of ATG16L1 
appeared on the western blot confirming the stable expression of truncated version of ATG16L1 
(Figure 12B). A smaller band of E226 version of ATG16L1 couldn’t be detected possibly because of 
instability of the protein. 
3.5 Analysis of canonical and non-canonical autophagy: To confirm that removal of WD domain of 
ATG16L1 didn’t affect canonical autophagy but created defect in LAP, cells from E230, E226 and  
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Figure 12: Role of WD domain in autophagy: A. Mouse embryonic fibroblasts (MEFs) isolated from 
control, E230 and E226 mice were grown in nutrient rich and starvation conditions (HBSS) for 2 
hours. Cells were lysed and immunoblotted for ATG16L1, p62, LC3 and loading control protein actin. 
Two bands corresponding to α and β isoforms of full length ATG16L1 (~66 kDa) were observed in the 
lanes for control lysates (con.) but no bands were seen in the lanes of E230 and E226 MEFs.  These 
were similar to the lane of MEFs with full length knock out of ATG16L1 (FL KO). This confirms the loss 
of full length ATG16L1 in E230 and E226 MEFs. Bands indicating p62 accumulation were seen in 
lysates of FL KO and E226 MEFs but not in control and E230 MEFs indicating loss of autophagy in FL 
KO and E226 MEFs. LC3-II bands corresponding to active autophagy were seen in control and E230 
MEFs with more LC3-II formation upon starvation. LC3-II bands were not detected in FL KO and E226 
MEFs confirming defective autophagy. Actin was used as loading control. B. Lysates of liver, muscle 
and brain from control, E230 and E226 mice were used for western blotting to detect ATG16L1. Full 
length ATG16L1 (~66 kDa) was detected in lysates from control mice whereas a small band of ~27 k 
Da, corresponding to size of ATG16L1E230 was seen in the lysates from E230 mice confirming the 
stable expression of truncated ATG16L1. 
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control mice were subjected to autophagy and LAP assays and results are described in the following 
section. 
3.5.1 Status of autophagy and LAP  in cells: Standard autophagy assays involve analysis of status of 
autophagosomal marker LC3 and  cargo adapter protein p62/SQSTM1 on western blots(70). 
Induction of autophagy is detected by appearance of a smaller sized LC3-II band (16 kDa) and very 
faint or no band for p62(70). As shown in figure 12A, MEFs from E230 mice showed LC3-II band and 
no p62/SQSTM1 band just like control MEFs. These results were comparable to MEFs from control 
mice confirming the presence of starvation induced autophagy in E230 mice. On the other hand 
absence of LC3-II band and high levels of p62/SQSTM1 in E226 and FL KO MEFs confirmed the defect 
in autophagy in these cells (Figure 12A). 
Similar results were observed in microscopy based autophagy assay using E230, E226 and control 
MEFs and skin fibroblasts (Figure 13A & B).MEFs and skin fibroblasts were grown in nutrient rich 
(Media) and starvation media (HBSS) before immunostaining them for LC3. As expected, multiple 
green fluorescent LC3 puncta were observed in control and E230 MEFs and skin fibroblasts grown in 
starvation media but not in nutrient rich media confirming successful induction of autophagy (Figure 
13A & B). No puncta were seen in E226 cells grown either in nutrient rich or starvation media 
confirming dysfunctional autophagy (Figure 13A & B).   
As shown in previous in vitro studies (67), further examinations were made to test the status of LAP 
in bone marrow derived macrophages (BMDMs)of WD deficient E230 and E226 mice along with their 
littermate controls. Pam3CSK4 coated polystyrene beads were used for phagocytosis assay on 
BMDMs and cells were immunostained for LC3. Although macrophages from all three genotypes 
showed phagocytosis of beads, only control macrophages showed translocation of LC3 to 
phagosomes containing beads which confirmed the absence of LAP in E230 and E226 macrophages 
(Figure 13C). Overall these results establish that loss of WD domain doesn’t disturb canonical 
autophagy in E230 mice cells but causes dysfunctional LAP.   
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Figure 13: Role of WD domain in autophagy and LAP: A&B. MEFs and skin fibroblasts from control, 
E230 and E226 mice were grown for 2 hours in nutrient rich (media) or starvation conditions (HBSS). 
Cells were fixed and stained for LC3. Starvation induced LC3 positive puncta in control (con.) and 
E230 MEFs and skin fibroblasts but not in E226 MEFs or skin fibroblasts indicating defective 
autophagy in E226 fibroblasts. C. BMDMs from control, E230 and E226 mice were incubated with 
Pam3CSK4 coated polystyrene beads for 90 minutes then fixed and stained for LC3. Phagocytosis of 
beads was seen in all the cells but only control cells showed LC3 positive phagosomes (zoomed in 
lower panel) indicating lack of LAP in both E230 and E226 BMDMs. Magnification 63X. Scale bar 10 
µm.   
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3.6 Summary: LAP deficient mice (named E230 mice) were generated by placing 2 stop codons at 
the end of CCD while preserving glutamate residues at 226 and 230 positions required for WIPI 
interaction and hence for autophagy (Figure 9 A-D). Insertion of stop codon at targeted location on 
exon 6 was confirmed by genotyping PCR (Figure 11A-B) and expression of truncated ATG16L1 was 
seen in cells and tissues via western blotting (Figure 12A & B). Cells from E230 mice showed 
activation of autophagy via microscopy (Figure 13A & B) and western blotting (Figure 12A). No LAP 
activity was detected in BMDMs of E230 mice after phagocytosis of polystyrene beads (Figure 13C). 
Another population of WD deficient mice were generated which lacked glutamate at 230 position on 
CCD (Figure 9A-D). These mice were named E226 mice and cells from them were found deficient in 
both autophagy and LAP via western blotting (Figure 12A) and microscopy respectively (Figure 13A & 
B).E226 mice acted as good control against E230 and control mice to compare between autophagy 
and LAP. 
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Chapter-4 
Analysis of role of WD domain in tissue homeostasis 
The experiments above demonstrated that cells cultured from the E230 mice lacking the WD domain 
of ATG16L1 could activate autophagy but were defective in non-canonical autophagy/LAP (Figures 
12A&13A-C). Further investigation was made regarding effect of loss of WD domain on tissue 
homeostasis. Tissues which does not make direct contact with microbes and do not fall in the 
category of immune organs were analysed to test the overall fitness of E230 and E226 mice. The 
following sections explain the role of WD domain in maintenance of tissue homeostasis in mice. 
4.1 Gross morphology, weight and fertility: 2-3 months old E230 and E226 mice were compared for 
their body sizes, body weights and fertility with their littermate controls. E230 mice were 
comparable in body size with controls whereas E226 mice were smaller (Figure 14A). Body weights 
were recorded every week and compared as growth rate curves (Figure 14B). E230 mice grew at the 
same rate as control mice but E226 mice showed retarded growth rate (Figure 14B). The E226 mice, 
unlike E230 and litter mate controls, were non-fertile (homozygous mating) and their breeding 
(heterozygous mating) didn’t follow Mendelian frequency (data not shown). The E230 and control 
mice lived more than 2 years whereas E226 mice had a maximum life span of 7 months (data not 
shown).  
4.2 Liver: 
The role of autophagy in maintenance of homeostasis in liver has already been reported. Komatsu et 
al(58)generated conditional liver specific autophagy knock out Atg7mice (Atg7F/F:Mx1-Cre, pIpC 
injected). The hepatocytes from these mice showed abnormalities in autophagosome formation, 
processing of LC3, GABARAP and GATE16, clearance of defective organelles such as mitochondria 
and peroxisomes upon starvation. Livers of these mice were abnormally large (hepatomegaly) with 
hepatocyte swelling, disorganised hepatic lobules and accumulation of ubiquitin tagged protein  
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Figure 14: Phenotype of E230 and E226 mice: A. Representative picture of 2 months old mice 
compares the full body size of control (ATG16L1), E230 (atg16l1E230) and E226 mice (atg16l1E226). 
E230 mice were similar to control mice whereas E226 mice were significantly smaller in size. Scale 
bar 1cm. B. Body weights recorded at regular intervals were plotted as growth curve showing 
growth lag in E226 mice compared to control and E230 mice. No growth defect was observed in 
E230 mice and they were comparable to littermate control mice. n = 11 and 6 for E230(atg16l1E230) 
and control (ATG16L1), respectively; n = 11 and 8 for E226 (atg16l1E226) and control, respectively. 
Data across control mice were pooled. Statistical analysis was done by unpaired t test. Error bars 
represents ±SEM. ****-P < 0.0001. 
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aggregates. Further liver damage markers such as alkaline phosphatase, aspartate aminotransferase 
(AST), alanine aminotransferase/ glutamic pyruvic transaminase (ALT/ GPT) were increased in the 
serum. Although these mice had normal function of proteasome machinery in liver, due to lack of 
autophagy the turnover of long life proteins was decreased (58). 
Likewise, livers from E230, E226 and litter mate controls were analysed for gross morphological 
features like size, weight and appearance. E230 livers were comparable to controls (5% body weight, 
average weight 1.6 g) whereas E226 livers were larger taking up 11% body weight with average 
weight of 2.6g (Figure 15A & B).  These results are similar to those recorded for mice lacking Atg7 
(58) or Atg5in liver (71). Serum analysis showed elevated ALT/ GPT in autophagy defective E226 mice 
but these enzymes were not raised in E230 mice compared to litter mate controls (Figure 15C).  
Status of autophagy was examined in liver lysates of E230, E226 and control mice by looking at levels 
of autophagy substrate proteins LC3-I and p62/SQSTM1.Results showed high levels of LC3-I and 
p62/SQSTM1 in E226 liver lysates compared to littermate controls however no such raised levels 
were detected in E230 liver lysates (Figure 15D).Liver sections of E230, E226 and control mice were 
therefore examined for the presence of p62/SQSTM1 inclusions.  p62/SQSTM1 inclusions were 
obvious in E226 but were not observed in E230 mice or littermate controls (Figure 15E).To further 
investigate the hepatomegaly, liver sections were examined for hepatocyte swelling as shown in 
liver specific atg7-/-mice (58). Measurement of hepatocyte circumference of H & E stained liver 
sections revealed large hepatocytes (>2 fold) in E226 livers as compared to E230 and controls (Figure 
16A). Also unlike Komatsu et al (58) large number of a mitotically active hepatocytes were detected 
in E226 livers sections upon immunostaining with anti Ki67/MKI67 antibody (Figure 16B). The 
numbers of Ki67 positive hepatocytes in E230 and control livers were comparable but much less (<4 
fold) than E226 livers (Figure 16B). These liver conditions correlated with hepatocellular 
hypertrophy. Also, it explains that hepatomegaly in autophagy deficient E226 mice is because of 
hepatocytes proliferation and hepatocyte swelling. Liver inflammation was analysed by  
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Figure 15: Role played by WD domain in maintaining liver homeostasis: A. Representative picture 
of livers from 2-3 months old control, E230 and E226 mice showing morphology. E226 livers were 
larger in size compared to E230 and control livers. E230 and control livers appeared similar. Scales 
bar 1cm. B. Percentage of liver to body weight ratios for 2-3 month old mice were plotted. E226 
mice weigh nearly twice as much as control and E230 livers indicating hepatomegaly in E226 livers. 
Weights of E230 and control livers were comparable. E230 n = 9, control n = 8; E226 n = 9, control n 
= 7. C. Serum levels of liver enzyme ALT/GPT were measured in 2-3 month old mice and represented 
as bar graph. ALT/GPT levels in E230 and control serums were similar whereas the levels were nearly 
5 fold higher in E226 serums indicated liver damage in E226 mice. E230 n = 7, control n = 5; E226 n = 
5, v control n = 5.D. Liver lysates from 3 different 2-3 month old mice were examined for autophagy 
substrate proteins. Status of p62 and LC3-I was comparable in E230 and control mice whereas these 
levels were high in E226 livers. Full length ATG16L1 was detected in control lysates but not in E230 
and E226 lysates. E. Liver sections from 2-3 month old control, E230 and E226 mice were stained for 
p62 and a representative image is shown. Control and E230 liver sections didn’t stain for p62 
whereas E226 liver sections showed multiple inclusions as highlighted in the enlarged lower panel. 
Arrows indicate p62 inclusions. In all figures data from littermate controls forE230 and E226 were 
pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM. ****-P <0.0001, 
***-P < 0.001; ns, non-significant. Image magnification 40X, scale bars: 50 μm. 
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immunostaining with anti Cd11b/ITGAM antibody specific for monocytes/ macrophages. The high 
staining of Cd11b (~7 fold against control, ~3 fold against E230) in E226 liver indicated increased 
infiltration of macrophages compared to E230 and littermate controls (Figure 16C) indicating liver 
inflammation in E226 mice. Slightly higher (>2-fold) macrophage infiltration was seen in E230 livers 
compared to their littermate controls indicating raised inflammation and a possible role of LAP in 
preventing liver inflammation (Figure 16C). 
In summary, above results confirm that livers of E230 mice appear and weigh like their littermate 
controls and didn’t show cell swelling or damage-induced cell proliferation (Figures 15A,B & 16A,B). 
E226 mice, on the other hand, had hepatomegaly, displayed damage induced cell proliferation, cell 
swelling and hence were similar to liver specific atg7-/- mice (58) (Figures15A,B &16A,B). Although 
only slightly higher levels of immune cell infiltration were seen in E230 livers, it was much less 
compared to E226 livers (Figure 16C).  
In another study, Takamura et al (71) generated mice (Atg5F/F;CAG-Cre) with mosaic deletion of Atg5 
in liver, muscle, brain and heart. These mice showed severe hepatomegaly at 6 months and 
developed multiple small benign tumours at the age of 9 months, only in liver but not in other 
organs. These tumours grew in size and number and covered the whole liver in 19 months. 
Hepatocytes only from tumour areas showed autophagy defects in the form of appearance of 
ubiquitin positive protein aggregates and p62 inclusions. These cells also showed signs of increased 
oxidative stress, DNA damage and accelerated cell proliferation, considered as hallmarks of 
tumorigenesis.  Takamura et al (71) further analysed liver specific Atg7 deficient mice (Atg7F/F; Alb 
Cre) made by Komatsu el al (72) and observed hepatic tumour formation similar to Atg5F/F;CAG-Cre 
mice. The size of hepatic tumours detected in Atg7F/F; Alb Cre mice reduced upon simultaneous 
deletion of p62 (Atg7F/F; Alb Cre; p62-/-) which pointed towards a role of p62 in tumour formation 
and progression. According to previous reports (73, 74) p62 inclusions trap and inactivate oxidative 
stress regulator protein Keap1 which leads to activation of transcription factor Nrf2. Accumulation of  
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Figure 16: Role of WD domain in preventing hepatomegaly and liver inflammation: A. Liver 
sections from control, E230 and E226 mice were stained with hematoxylin and eosin followed by 
examining under microscope and a representative image is shown. The circumference of 
hepatocytes were measured and plotted as bar graphs. Size of hepatocytes in control and E230 liver 
sections were comparable whereas E226 hepatocytes were nearly twice larger in size as highlighted 
in enlarged lower panel, representing cell swelling. B. Liver sections were examined for proliferating 
hepatocytes by staining for MKI67/Ki67. Ratios of number of Ki67 positive nuclei to total number of 
nuclei present in the 5 different fields were used for the plot. Normal levels of Ki67 positive nuclei 
were detected in control and E230 livers whereas nearly 7 fold increased staining was observed in 
E226 livers, as shown by arrows in lower enlarged panel, indicating damage induced cell 
proliferation. C. Liver sections were stained for Cd11b/ITGAM to examine for macrophage infiltration 
and a representative image is shown. Numbers of positive cells across 5 different fields were used 
for the plot. Nearly 2 fold higher levels of Cd11b staining was observed in E230 compared to control 
mice whereas the levels were more than 10 fold higher in E226 livers, as shown by arrows in lower 
enlarged panel, indicating liver inflammation. Livers form 2-3 months old mice were used in all the 
above experiments. n = 3 for all the strains in all the above experiments. Data across littermate 
control mice for E230 and E226 were pooled. Statistical analysis was done by unpaired t test. Error 
bars represents ±SEM.****-P < 0.0001, *-P < 0.1. Magnification 20X, scale bars: 50 μm. 
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Keap1 and activation of Nrf2 responsive factor Nqo1 (NAD(P)H dehydrogenase quinone 1) was 
noticed in Atg7F/F; Alb Cre mice but not in Atg7F/F; Alb Cre; p62-/-mice.  These data suggest that 
accumulation of p62 due to defective autophagy has role in tumour formation and progression. 
Moreover, only benign tumours were observed in these mice which didn’t get cancerous perhaps 
because of autophagy deficiency. Which suggest that although autophagy has a role in tumour 
suppression, once the tumours are formed it may play role in cancer development. Although p62 
inclusions were observed in E226 livers (Figures 15E), no tumours were seen.  This may be 
becauseE226 mice don’t survive more than 7 months which is less than the reported age of 9 
months to develop tumours (data not shown).  
4.3 Kidney: 
On morphological analysis, kidneys from E226 mice appeared smaller (~ 50%) than E230 and control 
kidneys but when their weights were normalised against whole body weight, the difference was 
non-significant (Figure 17A-C). When kidney lysates from E230, E226 and control mice were tested 
for the levels of autophagy substrate proteins, due to lack of autophagy, raised levels of LC3-I and 
p62/SQSTM1 were observed in E226 but not in E230 and control mice (Figure 17D-F). The presence 
of p62/SQSTM1inclusions was therefore tested in kidney sections via immunostaining and figure 17G 
shows distinct p62/SQSTM1 inclusions in autophagy deficient E226 kidneys. However, such 
inclusions were not noticed in E230 and control kidneys (Figure 17G). As published earlier, mice with 
lack of non-canonical autophagy/ LAP in myeloid cells, due to removal of Rubicon, showed 
deposition of immune complexes (IgG and C1q) in kidney glomeruli and other symptoms resembling 
SLE(62) however no such depositions were detected upon immunostaining for IgG autoantibodies in 
kidney sections of LAP deficient E230 or autophagy and LAP deficient E226 mice (data not shown).No 
other obvious histological differences were noticed between E230, E226 and control kidneys (data 
not shown). Although SLE like phenotype in kidney was not observed in E230 or E226 mice, it may 
develop in later age.  
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Figure 17: Role of WD domain in maintaining kidney homeostasis: A. Representative image 
comparing size and morphology of control, E230 and E226 kidneys is shown. E226 kidneys appeared 
smaller than E230 and control kidneys. Scale bar 1 cm. B&C. Kidney weights were recorded and 
plotted as weight and as percentage of ratio of kidney to body weight. E226 kidneys weighed less 
(E230 n = 8, control n = 8, E226 n = 7, control = 8) but when normalised for whole body weight (E230 
n = 9, control n = 8, E226 n = 7, control = 6), there was no significant difference found. D-F. Kidney 
lysates from three different mice were examined for autophagy substrate proteins. Raised levels of 
LC3-I and p62 were observed in E226 kidney lysate but not in control and E230 kidneys .Upon 
quantification, ~2 fold higher levels of LC3-I and ~6 fold higher levels of p62 was found in E226, than 
control and E230 kidneys. G. Kidney sections from control, E230 and E226 mice were stained for p62 
and a representative image is shown. No p62 staining was seen in control and E230 kidney sections 
whereas prominent p62 inclusions were detected in E226 kidneys as pointed by arrows in lower 
enlarged panel. G represents glomerulus. Data from control mice were pooled. Statistical analysis 
was done by unpaired t test. Error bars represent ±SEM.***-P < 0.001, **-P < 0.01; ns, non-
significant. Magnification 20X, scale bars: 50 μm. 
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4.4 Muscle: 
Important role of autophagy in maintenance of muscle homeostasis was shown by Masieroet al in 
2009 (75). They generated a muscle specific autophagy deficient mouse by making targeted deletion 
of Atg7.Cultured myofibers from these mice failed to generate autophagosomes upon starvation and 
contained p62/SQSTM1 aggregates.  At 2 months age, although indistinguishable in appearance, the 
muscle lacking ATG7 displayed various signs of atrophy and myopathy such as: decreased gain of 
muscle mass with age, loss-of-force production, decrease in myofiber size, vacuolated and centrally 
nucleated myofibers, muscle loss due to activation of apoptosis, accumulation of damaged 
mitochondria and sarcoplasmic distension. The loss in force generation was age-dependent as 5 
months old mice displayed increased loss in specific force compared to 2 month old mice.  atg7-/-
muscles from these mice also showed different set of morphological features for myopathy upon 
induction of catabolic conditions of muscle wasting like denervation and fasting. Denervation 
showed muscle loss, upregulation of several atrophy related genes and features including presence 
of abnormal myonuclei, accumulation of hematoxylin-positive inclusions and vacuolated areas which 
were not noticed in muscles from littermate control mice. Interestingly the size of ubiquitin positive 
p62 inclusions increased upon denervation of atg7-/-muscles. Upon fasting similar morphological 
features of muscle degeneration like hematoxylin-positive inclusions, vacuolated cytosol but smaller 
sized p62 inclusions were observed in atg7-/- but not in control muscles. However, upregulation of 
atrophy related genes was not observed. Hence, these observations conclude that autophagy plays 
different important roles in different conditions of muscle loss but was found crucial for 
maintenance of normal homeostasis in physiological and pathophysiological conditions.       
Gastrocnemius muscles from E230 mice appeared and weighed normal (Figure 18A & B). They didn’t 
display any of the abnormalities reported by Masieroet al for atg7-/-muscle, and hence were 
comparable to their litter mate controls. On the other hand gastrocnemius muscles of E226 mice 
were found significantly smaller than muscles of E230 and control mice indicating muscle wasting 
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Figure 18: Role of WD domain in maintaining muscle homeostasis: A. The representative image 
compares the morphology of gastrocnemius muscles of control, E230 and E226 mice. E226 muscles 
appeared smaller in size compared to control and E230 muscles Scale bar 1 cm. B. Muscle weights 
were recorded and plotted as percentage ratio against whole body weight. Muscles of E230 mice 
weighed as much as control mice but E226 muscles were significantly lighter indicated muscle 
wasting. E230 n = 6, control n = 5; E226 n = 8, control n = 6.C-E. Muscle lysates from three different 
controls, E230 and E226 mice were examined for autophagy substrate proteins. Accumulation of 
LC3-I and p62 was observed in E226 muscles whereas no accumulation was detected in E230 and 
control mice. Quantification of immunoblots confirmed the same results where ~2 fold higher LC3-I 
and ~4 fold higher p62 was found in E226 muscles compared to E230 and controls. F. Muscle 
sections were examined for p62 inclusions via immunostaining. No p62 staining was detected in 
control and E230 muscle sections whereas p62 inclusions were obvious in E226 muscles as pointed 
out by arrows in the lower enlarged panel. Muscles from 2-3 months old mice were used in all the 
above experiments. Statistical analysis was done by unpaired t test. Error bars represent ±SEM. ***-
P < 0.001, **-P < 0.01; ns, non-significant. Magnification 20X, scale bar: 50 μm. 
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(Figure 18A & B). Upon western blotting, accumulation of autophagy substrate proteins LC3-I and 
p62/SQSTM1 was seen in E226 muscle lysates indicating loss of autophagy (Figure 18C-E). E230 and 
control muscle lysates didn’t show LC3-I or p62/SQSTM1 accumulations confirming no defect in 
autophagy(Figure 18C-E).Further histological analysis showed p62/SQSTM1 aggregation in E226 
muscles but not in E230 and control muscles(Figure 18F).Further signs of muscle degeneration in 
myofibers like, decrease in size, excess vacuole formation and central nucleus etc., were not seen in 
E230, E226 and control mice up till 3 months of age (data not shown). 
4.5 Brain: 
The important role of autophagy in protection against neurodegenerative diseases has been 
emphasized previously. Komatsu et al(76) engineered neuron specific autophagy deficient mice by 
deleting Atg7(atg7f/f; nestin-cre). These mice were comparable to littermate controls at the time of 
birth but had retarded growth rate and couldn’t survive more than 28 weeks. Motor coordination 
and other behavioural deficits with abnormal limb-clasping reflexes and tremor were recorded. H & 
E staining of brain sections revealed atrophy of cerebral cortical region and reduction in number of 
Purkinje and similar cells in cerebellar cortex and hippocampal pyramidal cell layer. Upon 
immunostaining, brain sections showed increased neuronal damage marker, glial fibrillary acidic 
protein (GFAP) and increased apoptotic cell death. Although normal activity of proteasome was 
seen, ubiquitin positive inclusions were detected in the brain sections underlining important role of 
autophagy in clearance of long lived proteins. 
Brains from E230 mice along with littermate controls were examined for some of the above deficits. 
E230 brains appeared normal and were comparable to their littermate control brains in weights 
(Figure 19A-C). E226 mice brains looked smaller and weighed less compared to E230 and control 
mice however when normalised against whole body weight, they showed no significant difference 
(Figure 19A-C). Further examination of status of autophagy in brain lysates from E230, E226 and 
control mice was performed via western blotting. The brain lysates form E230 and control mice  
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Figure 19: Role of WD domain in maintaining brain homeostasis: A. Representative image 
comparing size and morphology of control, E230 and E226 brains is shown. E226 brains appeared 
smaller than E230 and control brains. Scale bar 1 cm. B&C. Brain weights were recorded and plotted 
as weight and as percentage of ratio of brain to body weight. E226 brains weighed less (E230 n = 8, 
control n = 7, E226 n = 7, control = 7) but when normalised for whole body weight (E230 n = 8, 
control n = 9, E226 E226) n = 6, control = 5), there was no significant difference found. D-F. Brain 
lysates from three different mice were examined for autophagy substrate proteins. Raised levels of 
p62 were observed in E226 brain lysate but not in control and E230 brains. Interestingly, LC3-I levels 
were comparable across brains lysates of all the three genotypes. Upon quantification, ~4-fold 
higher levels of p62 was found in E226, than control and E230 brains. G. Brain sections from control, 
E230 and E226 mice were stained for p62 and a representative image is shown. No p62 staining was 
seen in control and E230 brain sections whereas prominent p62 inclusions were detected in E226 
brain sections as pointed by arrows in lower enlarged panel. Brains from 2-3 months old mice were 
used in all the above experiments. Data from control mice were pooled. Statistical analysis was done 
by unpaired t test. Error bars represents ±SEM.***-P < 0.001, *-P < 0.1; ns, non-significant. 
Magnification 20X, scale bars: 50 μm. 
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didn’t show accumulation of LC3 and p62/SQSTM1 upon immunoblotting (Figure 19D-F). On 
contrary, E226 brain lysates showed ~4 fold higher levels of p62/SQSTM1 indicating defect in 
autophagy (Figure 19D-F). Interestingly, unlike other peripheral tissues, LC3-I levels were not raised 
in the brain lysates of E226 mice and were comparable to their littermate control brain lysates 
(Figure 19D-F). In the next step, brain sections of E230, E226 and control mice were investigated for 
the presence of p62/SQSTM1 inclusions. Brain sections from E230 and control mice  didn’t stain for 
p62/SQSTM1 indicating a lack of inclusions (Figure 19G) and functional autophagy.E226 brain 
sections, similar to atg7-/-mice, were full of p62/SQSTM1 inclusions indicating lack of autophagy 
(Figure 19G)(76). In spite of showing no obvious behavioural or motor coordination defects, some 
E230 mice developed head tilt (data not shown) which suggested there may be an abnormality in 
balance origination in the inner ear.  
4.6 Summary & discussion: 
As seen in morphological, behavioural, immunoblot and histological analysis of E230 and control 
mice, in liver, kidney, muscle and brain, loss of WD domain (and hence LAP) didn’t affect the status 
of autophagy and homeostasis. Slightly raised level of macrophages indicated liver inflammation 
(Figures 15-19) and possible role of LAP in limiting inflammation in liver. On the other hand E226 
mice due to lack of autophagy showed morphological and behavioural abnormalities with severely 
disturbed tissue homeostasis (Figures15-19) mirroring the ones reported by Komatsu et al(58), 
Masiero et al, (75), Komatsu et al, (76) and Yoshi et al (77). Surprisingly, normal levels of LC3-I in 
E226 brain lysates pointed towards the active status of autophagy in brain.  
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Chapter 5 
Analysis of ATG16L1 complex formation in liver and brain 
Autophagy is required for the neonatal survival of mice (57, 77). At the time of birth, mice (and most 
mammals) undergo a striking starvation because of discontinuation of trans-placental nutrition 
supply. This starvation period ends with the supply of mother’s milk. It is thought that autophagy 
allows mice to survive post-natal starvation by providing amino acids from protein degradation.  The 
precise role played by autophagy remains controversial as when compared with littermate control, 
atg5-/- mice died quickly after birth. Upon post mortem analysis, atg5-/- pups had low serum amino 
acids and no milk in stomach.  This suggested that postnatal starvation may result from a sucking 
defect.  The data in the previous chapters has shown that the E226 mice generated in this study are 
defective in autophagy but survive post-natal starvation (Figures 12A, 13A,B & 14A,B).  They grew 
more slowly than littermate controls but survived for 7 months (Figure 14B). It was therefore 
interesting to consider why the E226 mice survive but atg5-/- mice die after birth. 
During the course of this PhD Yoshii et al (77) rescued atg5-/- mice from neonatal lethality by 
restoring ATG5 expression in neurons. These mice survived for 6-8 months but, as seen for E226 
mice, had several systemic defects characteristic of loss of autophagy. Similarly, autophagy and LAP 
deficient E226 mice were small, weak, non-fertile, had disturbed tissue homeostasis and lived for 
maximum 7 months. These similarities suggested that E226 mice may have a low level of autophagy 
in neurons. This was supported by the observation that levels of LC3-I in the brain lysates of E226 
mice were similar to littermate controls and were not elevated as seen in peripheral tissues (Figure 
19D& E).  Autophagy requires the assembly of a multimeric ATG12–ATG5-ATG16L1 complex which 
associates with WIPI2 through the E230 and E226 residues in ATG16L1.  E226 contains glutamate 
226 and may associate weakly with WIPI2 and this may be sufficient for autophagy in brain, but not 
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peripheral tissues.  Gel filtration chromatography was therefore used to determine the sizes of 
ATG16L1 complexes in lysates from brain and liver, and determine if they contained WIPI2.  
5.1 Calibration of gel filtration column: Gel filtration separates proteins according to size with larger 
proteins eluting in early fraction (Figure 20A).  The gels were calibrated by following the elution of 
marker proteins of known size.  The ENrichTM SEC 650 column was calibrated with molecular size 
markers 29-700 kDa (Figure 20B). Figure 20Bshows that there was a linear relationship between 
protein size and elution volume and that the column would be able to resolve the size of ATG16L1 
complexes between 29 kDa and 700 kDa.  
5.2 Analysis of liver lysates: The analysis of liver lysates from control mice showed elution of full 
length ATG16L1, seen as a 66 kDa band, on western blot of fractions corresponding to a broad size 
range (600-150 kDa) (Figure 21A & B).  These fractions also contained ATG12-ATG5 (~ 52 kDa) and 
WIPI2 (49 kDa) (Figure 21A & B). This confirmed the formation of a large ATG16L1 complex and 
indirect evidence for interaction with ATG5-ATG12 and WIPI2 to propel autophagy. E230 liver lysates 
showed slightly slower elution of ATG16L1 suggesting a smaller size between 400-150 kDa (Figure 
21A). There was co-elution with ATG12–ATG5 but only faint signal for WIPI2 was detected in high 
molecular weight fractions (400 kDa) containing ATG16L1 (Figure 21A). This suggests that smaller 
sized ATG12-ATG5-ATG16L1 complex forms in E230 mice with possibly weak interactions with WIPI2 
but the immunoblot analysis (Figure 15D) presented in chapter 4 showed that this is still able to 
carry out autophagy. E226 liver lysates, similar to E230, showed ATG16L1 in later fractions along 
with ATG12–ATG5 but WIPI was not shifted to higher molecular size (Figure 21A). This suggested 
that the ATG16L1 complex in the liver lysates of E226 mice has very weak interaction with WIPI2. 
This would explain lack of autophagy in peripheral tissues and reconfirm the previously mentioned 
importance of glutamate residue at 230 position (E230) for WIPI2 binding and its role in carrying out 
autophagy (42) (Figures 8A,C&9D). 
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Figure 20: Calibration of gel filtration column: A. The graphical representation of gel filtration 
chromatography process and principle shown. The column is filled with porous beads and loaded 
with a mixture of two molecules A (pink and elongated) and B (green and round).  The column 
hinders the movement of the smaller molecule because it can pass through pores of column beads 
and takes longer to elute.  The larger elongated molecule cannot enter pores and elutes quickly. The 
elution peaks represent elution volumes (Ve) of A (Ve(A)) and B (Ve(B)). Due to its size and complete 
exclusion from beads, elution volume of A (Ve(A)) represents void volume (V0). B. The plot represents 
liner relationship between ratios of elution volume to void volume (Ve/V0) and log of molecular 
weights of standard proteins ranging 29 kDa-669 kDa. This plot was employed in the calculations of 
molecular weights of different fractions.  
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Figure 21: Analysis of ATG16L1 complex in liver and brain: A & B: Western blot analysis of liver 
lysates after gel filtration showed elution of ATG16L1 in 150-700kDa range in control, E230 and E226 
livers. While ATG12–ATG5 and WIPI2 were detected in the same range in control lysates, E230 
lysates showed movement of ATG12–ATG5 towards lower molecular weight with faint band of 
WIPI2 indicating weaker interaction. E226 lysates like E230 lysates showed migration of ATG12–
ATG5 towards lower range but didn’t show WIPI in that range indicating no interaction. C &D: 
Column purified brain lysates also showed similar pattern of co-purification of ATG16L1 and ATG12–
ATG5 in higher molecular weight range for controls but migration towards lower range in E230 and 
E226 brain lysates. Interestingly WIPI2 purification pattern was different from liver in all the three 
strains and it was restricted to lower molecular weight range indicating a different interaction 
pattern in brain. B&D compare the difference in WIPI2 pattern in the control liver and brain lysates.     
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5.3 Analysis of brain lysates: Analysis of brain lysates from control, E230 and E226 mice showed 
thatATG12-ATG5-ATG16L1 conjugate follows a similar pattern as seen in liver lysates, but it was not 
possible to detect movement of WIPI2 to high molecular weight fractions (Figure 21C & D).  Figure 
21B and D together compare the patterns of elution of ATG16L1, ATG12-ATG5 and WIPI2 in control 
liver and brain lysates highlighting the unusual elution of WIPI2 only in lower molecular weight 
fractions (150-65 kDa) unlike seen in liver lysates (600-150kDa).This suggested that the WIPI2 
interaction with ATG12–ATG5-ATG16L1 complex maybe weak in brain and that the weak interaction 
that might occur for E226, are sufficient to allow a low level of autophagy in the brain of E226 mice 
leading to their survival during the post-natal period. 
 
5.4 Discussion: The gel filtration analysis showed that full length ATG16L1 forms 600-300kDa 
complex in brain and liver (Figure 21A-D). In absence of WD domain, E230 and E226 tissues also had 
many intermediate sized 400-50kDa complexes which is consistent with the previously published 
results (69). Initial gel filtration based molecular size calculations suggested that an octamer of 
ATG16L1 binds to ATG12–ATG5 conjugate (69). A subsequent  analysis of ATG12–ATG5-ATG16L1 
complex by sucrose density sedimentation revealed dimer of ATG16L1 as an interactor to ATG12–
ATG5 conjugate (78). This can possibly happen if ATG16L1 makes an elongated conformation 
because of which it can get early elution form the size exclusion chromatography. In spite of 
differences in the size of formed complexes, WIPI2 interaction was seen in all of them (Figure 21A-
D). Due to presence of glutamate at 226 and 230 positions, the complete interaction of WIPI2 with 
full length ATG16L1 and ATG16L1E230 formed a functional complex capable to power autophagy, in 
liver, but not in case of ATG16L1E226 where loss of E226 formed non-functional complexes (Figure 
219A-D). 
E226 mice which lacked autophagy and LAP were weak, small, and infertile (Figure 14A). They had 
slower growth rate and showed disturbed homeostasis in liver, kidney, muscle and brain (Figures 
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14B-19). These mice resembled Atg5-/- used by Yoshii et al (77). Unlike previously showed autophagy 
null mice by deletion of Atg3, Atg5, Atg12, Atg16L1, E226 mice survived neonatal lethality imposed 
by starvation generated due to loss of placental nutrient supply (57-61). This can be possible 
because of additional function provided by ATG16L1E226 which was absent in other autophagy null 
mice. As seen in the gel filtration results that ATG16L1E226 can form complex with ATG12–ATG5 
which may have weak E3 ligase like activity to carry out low level of background autophagy in brain 
(Figure 21C & D). This was supported by further evidences of lesser p62/SQSTM1 inclusions in E226 
MEFs compared to ATG16L1 knock out MEFs (Figure 12A). As shown by Yoshii et al (77), restoration 
of autophagy in the brain of an autophagy null mice helped it to survive neonatal lethality, the 
process of autophagy in brain turns out to be critical compared to other tissues and hence may 
happen differently. This was confirmed by observation where autophagy deficient E226 brain lysates 
showed normal levels of LC3-I comparable to their littermates (Figure 19D & E). Also the gel filtration 
analysis displayed a unique pattern of WIPI2 interaction with ATG12–ATG5-ATG16L1 complex in 
brain tissue compared to liver (Figure 21 B & D). These results all together can be used to conclude 
that E226 mice maintained a small amount of autophagy in brain which helps them survive post 
birth starvation although the same was not true in other tissues which results in loss of homeostasis 
in liver, kidney, muscles and brain (Figures 15-19). 
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Chapter-6 
Cytokine analysis 
Cytokines are small extracellular messenger molecules (mostly glycoproteins) which act as bridge 
between innate and adaptive immune components to remove invading pathogen or overcome a 
tissue damage. Upon pathogen entry or tissue damage, immune cells like macrophages or helper T 
cells release cytokines which can perform various functions based on their interaction with the 
subsequent target immune cells. Based on their effect, cytokines can be of proinflammatory (IL-1β, 
IL-8, and IFN-γ) or anti-inflammatory (IL-4, IL-10, and IL-13) type. This process is tightly regulated as 
an improper cytokine response can lead to inflammatory disorder. 
Macrophages play an important role in the removal of dead cells and cells dying through apoptosis 
by phagocytosis. These internalised dead cells are then quickly processed for degradation in 
lysosome via LC3-associated phagocytosis (LAP). This process of clearing apoptotic or dead cells by 
macrophages is called “efferocytosis”. Failure in efferocytosis triggers inflammatory cytokine 
response. Work published during the course of this thesis by Martinez et al (50) described a mouse 
deficient in RUBICON/RUBCN in all tissues. In this report, RUBICON was shown as an essential player 
for LAP signalling but not autophagy as rubcn-/-mice displayed active autophagy but defective LAP. 
RUBICON as part of class III PI3P kinase complex, facilitates VPS34 activity and sustained Ptdins3P 
presence on LAPosomes. RUBICON also helps in recruitment as well as stabilisation of NOX2 complex 
required for generation of reactive oxygen species needed for LAP but not for autophagy. Hence 
rubcn-/-mice were generated to study the LAP defect in presence of autophagy. These mice showed 
raised serum cytokine (G-CSF, IL1-α, IL1-β, IL-6 & KC) levels upon Aspergillus fumigatus infection. 
Further Martinez et al (62) generated another mouse where targeted deletion of RUBICON/RUBCN 
in myeloid cells was used to generate a mouse defective in LAP.   Work with the rubcn-/- mouse has 
demonstrated that LAP-deficient mice showed accumulation of dead and apoptotic cells in tissues 
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and in the cytoplasm of macrophages. These dead cells which are present in circulation, trigger 
immune responses like secretion of pro-inflammatory cytokines and production of autoantibodies 
(mostly against nuclear antigens) and leads towards the development of SLE. Although considered as 
“immunologically silent process”, efferocytosis triggers immune signalling for the production of anti-
inflammatory cytokines to prevent tissue damage.   
The serum of young (8-12 weeks) and aged (20-24 weeks) E230 (LAP-/-), E226 (autophagy-/-& LAP-/-) 
with littermate control mice were therefore tested for the presence of autoantibodies and 
cytokines. It was not possible to detect anti-nuclear autoantibodies (data not shown) but raised 
levels of proinflammatory IL6 and CCL2/MCP1 were detected in E226 mice and these raised levels 
were absent from E230 and control mice (Figure 22). Comparable serum levels of IL1B, IL12 (p70), 
IL13, and TNF/TNF-α were found in E230, E226 and control mice (data not shown). Therefore, the 
complete LAP defective E230 mice did not appear to show any pro-inflammatory and autoimmune 
conditions displayed by macrophage specific LAP-/- mice lacking RUBCN. Based on above 
observations it seems that systemically, autophagy but not LAP plays key role in the regulation of 
inflammatory response against infection or tissue damage. 
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Figure 22: Role of WD domain on cytokine levels: Serum cytokine levels from young (2-3 months) 
and aged (~24 months) mice were analysed via LUMINEX assay system. A. Nearly two fold increase 
in the serum levels of IL6 was observed in young E226 mice compared to control mice but not in 
young E230 mice. No significant difference was observed in IL6 levels in aged mice of all three 
genotypes. B. Similarly, significantly higher levels of CCL2 were seen in young E226 mice serums 
compared to E230 and control mice. The levels of CCL2 were increased in aged E230 mice but not in 
aged controls and E226 mice serums.  
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Chapter-7 
Discussion: 
The WD40 domain contributes to more than half the amino acids of ~66 kDaATG16L1 in higher 
eukaryotes like nematodes, insects, plants and humans.  The ATG16 of yeast cells doesn’t have WD 
domain yet they can activate autophagy (Figure 7A). Similarly, the WD domain is not required for 
autophagy in higher eukaryotes(67).  This suggests that the WD domain has been added to ATG16L1 
during evolution to operate in pathways other than canonical autophagy. The work in this thesis and 
the work of others (Fletcher, Martinez etc.) shows that the WD domain is required for non-canonical 
autophagy pathways that monitor the uptake of extracellular material by phagosomes, endosomes 
and macropinosomes.  This allows unwanted external material and pathogens to be removed quickly 
to lysosomes for degradation.  Targeting to lysosomes involves recruitment of LC3 to the endo-
lysosome compartments and cells do this by co-opting the proteins used to conjugate LC3 to 
autophagosomes during canonical autophagy. 
Fibroblasts and macrophages isolated from E230 mice couldn’t activate LAP which confirmed the 
results of previous report stating that WD domain is required for several non-canonical autophagy 
like pathways which recruit LC3 on to endocytic compartments (Figure 13C) [61]. These 
compartments can be macropinosomes, phagosomes containing latex beads, dead cells or 
pathogens, swollen endosomes due to monensin or combination of ammonium chloride with 
vacuolating toxin A (of Helicobacter pylori)treatment. Loss of WD domain also hampered the 
deposition of LC3 on endosomes targeted by proton channel encoded by influenza virus (67). 
Furthermore, WD domain was also proved to be important in processes like secretion of TNF, IL1β 
by dendritic cells in response to CLEC4N/ Dectin2 signalling (79) and also reduced antigen 
presentation (67).   
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WD domain forms a complex of 7 bladed β propellers and known for providing a scaffold/ platform 
for protein interaction (Figure 7C). The loss of function studies described in [61]suggest that the 
protein interaction platform provided by WD domain is critical for ensuring the quality control of 
endocytic pathways ensuring quick removal of damaged material entering cells by endocytosis or 
endosomes/phagosomes containing pathogens or dead cells. These important functions must be the 
reason for the evolution of this large domain at the C terminus of ATG16L1. Moreover, the same can 
be further strengthened by the findings confirming interaction of WD domain of ATG16L1 with NOD 
like receptors (NLRs) (80), MEFV/TRIM20 (25), TMEM (81) and EVA1A/TMEM166 (82) which are 
important for pathogen recognition.  
Mice having conditional KO of LAP in phagocytic cells (macrophages, neutrophils, monocytes) by Lys-
Mcre driven loss of RUBCN or CYBB/NOX2 grew slowly and later developed SLE (50, 62).  In contrast 
the E230 mice which lack LAP, described in this thesis, grew normally and over the time frame 
tested, did not develop obvious SLE (Figure 14A & B). This maybe because the E230 mice have 
systemic loss of LAP and may have compensated for loss of LAP in phagocytic cells. In other words, 
inactivation of LAP via removal of WD domain or by deletion of RUBCN and CYBB/NOX2 might 
happen through different mechanisms. In the next step it will be interesting to see if WD domain 
interacts with RUBCN or UVRAG or components of CYBB/ NOX2 complex. In spite of lacking a very 
important function of pathogen removal and maintenance of quality of endosomal vesicles, the E230 
mice with systemic loss of LAP didn’t show any obvious abnormality and had intact tissue 
homeostasis (Figures 14-19). Only in few cases E230 mice developed head tilt which might be 
because of infection in the internal ear due to lack of LAP but needs further investigation (data not 
shown).  
This thesis only emphasized the role of LAP in tissues that doesn’t come in direct contact with 
microbiota/pathogens which indeed is more important question to address. This study significantly 
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establishes LAP-/- E230 mice fit for further infection studies and next stage experiments based on 
bacterial and viral infection will provide key insight about exact in vivo role of LAP.   
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tissue homeostasis in mice independently of the WD domain required for
LC3-associated phagocytosis
Shashank Raia*, Maryam Arasteha*, Matthew Jeffersona*, Timothy Pearsona, Yingxue Wanga, Weijiao Zhanga,
Bertalan Bicsaka, Devina Divekara, Penny P. Powella, Ronald Naumannb, Naiara Berazac, Simon R. Cardingc,
Oliver Floreyd, Ulrike Mayer e, and Thomas Wilemana,c
aNorwich Medical School, University of East Anglia, Norwich, Norfolk, UK; bMax-Planck-Institute of Molecular Cell Biology and Genetics, Dresden,
Germany; cQuadram Institute Bioscience, Norwich, Norfolk, UK; dSignalling Programme, Babraham Institute, Cambridge, UK; eSchool of Biological
Sciences, University of East Anglia, Norwich, Norfolk, UK
ABSTRACT
Macroautophagy/autophagy delivers damaged proteins and organelles to lysosomes for degradation,
and plays important roles in maintaining tissue homeostasis by reducing tissue damage. The transloca-
tion of LC3 to the limiting membrane of the phagophore, the precursor to the autophagosome, during
autophagy provides a binding site for autophagy cargoes, and facilitates fusion with lysosomes. An
autophagy-related pathway called LC3-associated phagocytosis (LAP) targets LC3 to phagosome and
endosome membranes during uptake of bacterial and fungal pathogens, and targets LC3 to swollen
endosomes containing particulate material or apoptotic cells. We have investigated the roles played by
autophagy and LAP in vivo by exploiting the observation that the WD domain of ATG16L1 is required for
LAP, but not autophagy. Mice lacking the linker and WD domains, activate autophagy, but are deficient
in LAP. The LAP−/- mice survive postnatal starvation, grow at the same rate as littermate controls, and are
fertile. The liver, kidney, brain and muscle of these mice maintain levels of autophagy cargoes such as
LC3 and SQSTM1/p62 similar to littermate controls, and prevent accumulation of SQSTM1 inclusions and
tissue damage associated with loss of autophagy. The results suggest that autophagy maintains tissue
homeostasis in mice independently of LC3-associated phagocytosis. Further deletion of glutamate E230
in the coiled-coil domain required for WIPI2 binding produced mice with defective autophagy that
survived neonatal starvation. Analysis of brain lysates suggested that interactions between WIPI2 and
ATG16L1 were less critical for autophagy in the brain, which may allow a low level of autophagy to
overcome neonatal lethality.
Abbreviations: CCD: coiled-coil domain; CYBB/NOX2: cytochrome b-245: beta polypeptide; GPT/ALT:
glutamic pyruvic transaminase: soluble; LAP: LC3-associated phagocytosis; LC3: microtubule-associated
protein 1 light chain 3; MEF: mouse embryonic fibroblast; NOD: nucleotide-binding oligomerization
domain; NADPH: nicotinamide adenine dinucleotide phosphate; RUBCN/Rubicon: RUN domain and
cysteine-rich domain containing Beclin 1-interacting protein; SLE: systemic lupus erythematosus;
SQSTM1/p62: sequestosome 1; TLR: toll-like receptor; TMEM: transmembrane protein; TRIM: tripartite
motif-containing protein; UVRAG: UV radiation resistance associated gene; WD: tryptophan-aspartic acid;
WIPI: WD 40 repeat domain: phosphoinositide interacting
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Introduction
Autophagy generates autophagosomes that deliver cyto-
plasmic material to lysosomes for degradation.
Macroautophagy, hereafter referred to as autophagy, is
activated during starvation and provides a short-term
supply of amino acids to sustain protein synthesis and
energy production. At the same time, basal autophagy
helps to prevent tissue damage during development and
ageing by reducing the accumulation of damaged proteins
and organelles [1,2]. Autophagosome formation involves
the recruitment of LC3 from the cytosol to the limiting
membrane of the phagophore where it provides a binding
site for autophagy cargoes, and facilitates fusion with
lysosomes. Recent studies [3] show that LC3 is also
recruited to membranes by an autophagy-related pathway
called LC3-associated phagocytosis (LAP). LAP is acti-
vated by TLR signalling and NADPH oxidase during pha-
gocytosis of fungal and bacterial pathogens, and results in
attachment of LC3 to the cytosolic side of the phagosome
membrane where it facilitates phagosome maturation [4].
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A similar LAP-like noncanonical autophagy pathway also
operates in nonphagocytic cells resulting in recruitment of
LC3 to single-membraned endolysosomal compartments
during entosis, micropinocytosis [5] and following lysoso-
motropic drug treatment [6,7], and may occur during the
uptake of particulate material or apoptotic cells [8–11].
Autophagy and LAP provide 2 different pathways for
removing unwanted material from cells, but the relative
roles played by each pathway in reducing tissue damage and
maintaining homeostasis in vivo are not clear. Autophagy-null
mice die shortly after birth because they are unable to adapt to
the starvation that follows loss of placental nutrition [12].
Mice with tissue-specific loss of autophagy survive, but the
tissues lacking autophagy invariably accumulate ubiquitin-
positive inclusions containing protein aggregates and show
signs of inflammation and tissue damage. These studies have
inactivated autophagy genes such as Atg3, Atg5, Atg7, Atg12
and Atg16L1 [12–16] that are essential for both autophagy
and LAP, making it impossible to determine if tissue damage
results from loss of autophagy, or LAP, or both. Studies on
LAP in vivo have focused on inactivation of RUBCN/Rubicon
in myeloid cells [3,4]. rubcn−/- myeloid cells are LAP-deficient
and show defects in clearance of bacterial and fungal patho-
gens and dying and apoptotic cells. These mice also have
elevated levels of inflammatory cytokines, and eventually
develop an autoimmune disease that resembles systemic
lupus erythematosus (SLE) [4,17]. While suggestive of a role
for LAP in preventing inflammation and autoimmunity, the
targeted loss of RUBCN from myeloid cells does not inform
on the role played by LAP in non-myeloid cell types in vivo.
The recruitment of LC3 to membranes during both autop-
hagy and LAP requires the E3 ligase-like activity of the
ATG12–ATG5-ATG16L1 complex, which covalently binds
LC3 to membranes. ATG16L1 contains an N-terminal
domain that binds the ATG12–ATG5 conjugate (Figure 1),
followed by a coiled-coil domain (CCD) that binds WIPI2
[18]. WIPI2 brings the ATG12–ATG5-ATG16L1 complex to
phagophore membranes allowing conjugation of LC3 to
phosphatidylethanolamine [19]. In higher eukaryotes, a linker
region attaches the CCD to a large C-terminal WD (trypto-
phan-aspartic acid) domain containing 7 WD repeats folded
into a circular β-propeller [20,21]. Recent studies show that
the WD domain of ATG16L1 is required for LAP [22]. This
allowed us to generate LAP-deficient mice by inserting 2 stop
codons in frame at the end of the CCD of the Atg16L1 gene
(Figure 1). This mutation, called atg16l1E230, allowed transla-
tion of the glutamate E226 and E230 residues in the CCD
required for WIPI2 binding and autophagy [18], but pre-
vented translation of the linker region and WD domain
required for LAP. In a second mouse, called atg16l1E226, an
unexpected recombination removed the E230 glutamate resi-
due required for WIPI2 binding. This mouse survived post-
natal starvation but was defective in autophagy and LAP in all
tissues. We have used these 2 mouse strains to determine the
roles played by autophagy and LAP in reducing tissue damage
and maintaining tissue homeostasis in vivo.
Results
Mice lacking the WD and linker domain of ATG16L1 were
generated by homologous recombination in embryonic stem
cells. The targeting vector was designed to insert 2 stop
codons after glutamate residue E230 in the CCD, followed
by the bovine growth hormone polyadenylation site and a frt-
flanked neomycin cassette. Homologous recombination was
verified by Southern blotting. RNA analysis of the F1 genera-
tion established from independent chimeras showed that most
mice carried the correct sequence and expressed the E230
residue required for autophagy. Surprisingly, some mice had
a 14 base pair (bp) deletion at the end of the CCD, which
deleted glutamate E230 and its preceding amino acid,
Figure 1. Generation of mice lacking the WD and linker domains of ATG16L1. (A) Domain structure of ATG16L1. The N-terminal ATG5 binding domain (ATG5 b) binds
the ATG12–ATG5 conjugate. The coiled-coil domain (CCD) binds WIPI2 through glutamates E226 and E230. A linker domain separates the CCD from the 7 WD repeats
of the WD domain. (B) Sites of stop codons. atg16l1E230; 2 stop codons were inserted into exon 6 immediately after glutamate E230 to preserve binding sites for
WIPI2, but prevent translation of the linker and WD domain. atg16l1E226; an unexpected recombination inserted a glycine residue at position 228. (C) Tissue lysates
were separated by SDS-PAGE and transferred to nitrocellulose membranes. Separate membranes sections were analyzed by western blot using antibody specific for
ATG16L1.
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followed by a stop codon (Figure 1 A and B). These mouse
strains were termed atg16l1E230 and atg16l1E226.
Expression of the truncated ATG16L1E230 CCD was ver-
ified by comparing western blots of tissue lysates from the
atg16l1E230 mice with littermate controls (Figure 1C). The
ATG5 binding and CCD of ATG16L1 migrated at ~ 27 kDa
compared to the ~ 70 kDa for full-length ATG16L1. As
described by Mizushima et al [21], lysates from liver showed
the α and β isoforms of ATG16L1 while the slower migrating
β isoform predominated in muscle and brain. Full-length
ATG16L1 was present in lysates obtained from littermate
controls, but absent from tissues of atg16l1E230 mice. It was
not possible to detect the truncated CCD of the atg16l1E226
mice, in whole tissue lysates. This may be because the epitope
is lost, or the protein is highly unstable.
The size of the ATG16L1 complex generated in the mice was
determined by gel filtration of cytoplasmic fractions isolated
from homogenized liver (Figure 2). In control mice the α and
β isoforms of ATG16L1 eluted in high molecular-mass fractions
suggesting formation of a 300–600 kDa complex. Previous work
has shown that elution of ATG16L1 in high molecular-weight
fractions is dependent on ATG5 [21]. The presence of the
ATG12–ATG5 conjugate in the same high molecular weight
fractions as ATG16L1 suggested binding of ATG5 to the
N-terminal ATG5-binding domain present in the CCD of
ATG16L1. Full-length ATG16L1 contains the E226 and E230
Figure 2. Analysis of ATG16L1 complexes in liver by gel filtration. The cytosolic fraction of liver homogenates was separated by size-exclusion chromatography on an
ENrichTMSEC 650 column. Fraction (0.5 ml) were analyzed by immunoblot for ATG16L1, ATG5 and WIPI2 as indicated. Void volume 10 ml. Migration and elution of
molecular mass standards are shown (kDa).
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glutamate residues required for WIPI2 binding, and indirect
evidence for binding to WIPI2 was provided by the elution of
the 49-kDa WIPI2 protein in high molecular-mass factions ran-
ging between 150 and 600 kDa. Analysis of the atg16l1E230 and
atg16l1E226 mice was complex because the preparation of liver
lysates appeared to result in limited proteolysis of CCDs, and the
possible formation of dimers and trimers resistant to dissocia-
tion during SDS polyacrylamide electrophoresis (Fig. S1). The
blots in Figure 2 show the elution profile of the 27-kDa CCD and
the 25-kDa proteolytic products, which co-elute with multimers
at 50 and 75 kDa (Fig. S1). The bulk of the CCD in the liver of
atg16l1E230 mice eluted over a broad range from 50–400 kDa in
fractions which also contained the ATG12–ATG5 conjugate and
ATG5. As seen for control mice, WIPI2 was detected in high
molecular-mass fractions eluting between 400–600 kDa; how-
ever, levels of WIPI2 were less than seen for control, and a low
molecular-mass fraction was also detected between 50 and 100
kDa. The CCD of atg16l1E230 mice retained binding sites for
ATG5 and WIPI2, and the elution profiles were consistent with
assembly of complexes containing the CCD, ATG12–ATG5 and
WIPI2. Unlike whole tissue lysates, it was possible to detect the
CCD of the atg16l1E226 mouse in fractions eluting from the gel
filtration column. The CCD eluted over a broad 30–400 kDa
range in fractions that also contained ATG12–ATG5. The CCD
of atg16l1E226mice lacks the E230 glutamate residue required for
WIPI2. The blots show that unlike control mice and atg16l1E230
mice, it was not possible to detectWIPI2 in highmolecular-mass
fractions, andWIPI2 eluted between 50 and 100 kDa. The results
from this indirect assay based on the size of ATG16L1 complexes
suggest that the CCD of atg16l1E226 assembles with ATG12–
ATG5 through the ATG5 binding domain, but does not bind
strongly to WIPI2.
The ability of cells isolated from the mice to activate
autophagy was tested by western blot of autophagy substrates
SQSTM1/p62 (sequestosome 1) and LC3, and by following
formation of LC3 puncta after starvation in Hanks balanced
salt solution (HBSS) (Figure 3A-C). Mouse embryonic fibro-
blasts (MEFs) from mice lacking ATG16L1 (atg16l1−/-) were
used as an autophagy-negative control. MEFs from control
mice expressed the α and β isoforms of ATG16L1 which were
absent from atg16l1−/-, atg16l1E226 and atg16l1E230MEFs,
whereas atg16l1E230 MEFs showed the smaller band expected
at 27 kDa (data not shown). atg16l1−/- MEFs showed defects
in autophagy indicated by the expression of high levels of the
autophagy substrate SQSTM1, and an inability to generate
lipidated LC3-II (Figure 3A) after starvation. MEFs expressing
ATG16L1E226 also expressed high levels of SQSTM1 and were
unable to generate lipidated LC3-II showing that loss of E230
resulted in defects in autophagy. This supported the observa-
tion that MEFs (Figure 3B) and skin fibroblasts (Figure 3C)
from atg16l1E226 mice were unable to generate LC3 puncta
following starvation. In contrast, cells expressing full-length
ATG16L1, or expressing the CCD but lacking the WD
domain (ATG16L1E230) were able to activate autophagy, indi-
cated by low basal levels of SQSTM1 and generation of LC3
puncta in response to HBSS (Figure 3B,C). Taken together,
these results showed that autophagy requires the E226 and
E230 glutamate residues in the CCD needed for WIPI2 bind-
ing, but, as reported previously [19], autophagy did not
require the WD domain. The role played by the WD domain
during LAP was analyzed by incubating bone marrow-derived
macrophages (BMDMs) from the mouse strains with
Pam3CSK4 (a mimic of bacterial lipopeptides)-coupled poly-
styrene beads to follow LC3 translocation to phagosomes
(Figure 3D). LC3 was recruited to phagosomes in macro-
phages from control mice, but not in macrophages from
autophagy-defective atg16l1E226 mice, or atg16l1E230 mice
that lack the WD domain and linker region of ATG16L1. As
Figure 3. Role played by WD and linker domains of ATG16L1 during autophagy and LC3-associated phagocytosis. (A) MEFs from mice lacking ATG16L (FL KO),
atg16l1E226 (E226) and atg16l1E230 (E230) and appropriate littermate controls were incubated in complete media or HBSS for 2 h to induce autophagy. Cell lysates
were analyzed by western blot using antibodies specific for the indicated proteins. (B) MEFs or skin fibroblasts (C) from atg16l1E226 (E226) and atg16l1E230 (E230) mice
and littermate controls were incubated in complete media or HBSS for 2 h to induce autophagy. Cells were immunostained for endogenous LC3. (D) BMDMs from
atg16l1E226 (E226) and atg16l1E230 (E230) and appropriate littermate controls were incubated with Pam3CSK4-coupled polystyrene beads for 1.5 h in complete
medium to induce LAP, and immunostained for endogenous LC3 (green). Boxed regions highlighting internalized beads are enlarged and shown in the lower panel.
Magnification 63X, scale bars: 10 µm.
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reported previously [22,23] these observations indicate that
the WD domain is required for LAP in myeloid cells, and
confirmed that the atg16l1E230 mouse would provide a LAP-
deficient mouse model to study the role played by LAP in
maintaining tissue homeostasis in vivo.
Mouse growth and survival
The LAP-deficient atg16l1E230 mice survived the postnatal leth-
ality seen in atg16l1−/- mice [15], and were similar in size and
weight to littermate controls and grew at comparable rates
(Figure 4A, B). atg16l1E230 mice were born with Mendelian
frequency with reproductive organs of normal size, and were
fertile with a reproductive capacity comparable to controls (data
not shown). The survival rate and litter sizes of atg16l1E230 mice
were similar to wild-type mice with life spans of at least
24 months (data not shown). The majority of atg16l1E226 mice
also survived postnatal lethality, but most grew slowly
(Figure 4A, B) and died within 5–7 months of age.
Inflammatory cytokines
LAP-deficient mice generated by Lyz2/LysM-cre-driven loss of
Rubcn frommacrophages, monocytes and neutrophils (3) develop
a SLE-like syndrome characterized by an age-dependent increase
in serum cytokines and eventual generation of antibodies against
nuclear antigens. Serum levels of IL1B, IL12 (p70), IL13, TNF, IL6
and CCL2/MCP1 reported to be elevated in rubcn−/- mice were
measured in control, atg16l1E230 and atg16l1E226 mice. Serum
levels of IL1B, IL12 (p70), IL13, and TNF/TNF-α in atg16l1E230
and atg16l1E230 mice were the same as littermate controls at 8–12
and 20–24 wk. Elevated levels of IL6 and CCL2/MCP1 were
detected in the autophagy-defective atg16l1E226 mice, but these
were not seen in control or atg16l1E230 mice (Fig. S2). It was not
possible to detect antinuclear antibodies able to stain the nuclei of
cells in culture. The LAP−/- atg16l1E230 mice do not therefore
appear to develop the pro-inflammatory phenotype seen for
rubcn−/- mice lacking LAP in phagocytic cells.
Liver
A preliminary survey of the internal organs of the mouse strains
showed that defects were most obvious in the liver of the autop-
hagy-defective atg16l1E226 mice. The livers (Figure 5A) showed
pronounced hepatomegaly with average liver weights of 2.6 g,
compared to 1.6 g of control mice, and when liver weight was
expressed as percentage of body weight (Figure 5B) to compensate
for the smaller size of the atg16l1E226mouse, livers weremore than
twice the size (11%) of littermate controls (5%). These results are
in line with studies of mice with targeted loss of Atg7 in liver [13],
or the hepatomegaly observed in atg5−/- mice where Atg5 is
restored in neuronal tissue [24]. Liver damage was evident from
elevated levels of serum GPT/ALT (glutamic pyruvic transami-
nase, soluble), a liver function marker enzyme (Figure 5C). In
contrast, there was little evidence for hepatomegaly in atg16l1E230
LAP-deficient mice with mean weights of 1.8 g being the compar-
able to littermate controls, and these mice did not show the raised
serum GPT/ALT levels seen in autophagy-defective mice.
Autophagy function in liver tissue was assessed by western blot
of SQSTM1 and LC3, which are substrates for autophagy and are
degraded in lysosomes. The signals for full-length ATG16L1 were
present in blots of 3 representative livers taken from control mice.
Two bands were seen, consistent with the expression of α and β
isoforms of ATG16L1 in liver [21], but absent from blots of
atg16l1E226 and atg16l1E230 mice (Figure 5D). Liver lysates from
the atg16l1E226mouse showed raised levels of LC3-I and SQSTM1
compared to control mice, suggesting impaired clearance of
autophagy substrates ‘in vivo’ (Figure 5D). Immunohistological
analysis showed SQSTM1 inclusions in hepatocytes, indicative of
accumulation of damaged proteins and organelles in atg16l1E226
mice (Figure 5E). In contrast livers from the LAP-deficient
atg16l1E230 mice were similar in size to littermate controls
(Figure 5A), and lysates did not reveal raised levels of LC3-I and
SQSTM1 (Figure 5D).Moreover, SQSTM1 inclusions were absent
from hepatocytes (Figure 5E), suggesting that autophagy is active
in the liver. Further analysis confirmed that hepatomegaly in
atg16l1E226 mice correlated with hepatocellular hypertrophy as
evidenced by the enlarged circumference of hepatocytes
(Figure 6A) and increased hepatocyte proliferation indicated by
a 4-fold increase in MKI67/Ki67 immunostaining (Figure 6B).
Figure 4. Phenotype of atg16l1E226 and atg16l1E230 mice. (A) Representative pictures of mice at ~2 months of age (scale bar: 1 cm). (B) Body weight of mice and
littermate controls fed on chow diet. Mice were weighed at the indicted times and each point is generated from at least 6 individuals (n = 11 and 6 for E230
(atg16l1E230) and control, respectively; n = 11 and 8 for E226 (atg16l1E226) and control, respectively. Statistical analysis was done by unpaired t test. Error bars
represents ±SEM. ****-P < 0.0001.
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Figure 5. Analysis of autophagy substrates in liver. Panel (A) Representative livers at ~2 months (scale bar: 1 cm). (B) Liver weight expressed as a percentage of body
weight at 2–3 months of age. E230 (atg16l1E230) n = 9, control n = 8; E226 (atg16l1E226) n = 9, control n = 7. (C) GPT/ALT in serum from mice aged between
2–3 months. E230 (atg16l1E230) n = 7, control n = 5; E226 (atg16l1E226) n = 5, v control n = 5. (D) Western blot of liver lysates from 3 representative mice. Membranes
strips taken from the appropriate molecular weight range were analyzed separately using the indicted antibodies. (E) Representative histochemical sections of livers
immunostained for SQSTM1. Enlarged regions of interest are shown in the lower panel. Arrows: SQSTM1 inclusions. In all figures data from littermate controls for
E230 and E226 were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM. ****-P < 0.0001, ***-P < 0.001; ns, non-significant. Image
magnification 40X, scale bars: 50 µm.
Figure 6. Analysis of liver homeostasis. (A) Representative images of H&E-stained sections of livers. Boxed regions of interest are enlarged in lower panels. The bar
graph represents comparative circumferences of hepatocytes (n = 10) across the indicated strains (n = 3 for all the strains). (B and C) Representative histochemical
sections of liver immunostained with antibodies against MKI67/Ki67 (B) or ITGAM/Cd11b (C). Regions of interest are enlarged and shown in lower panels. Arrows
indicate positive staining. Bar graphs show number of positive cells (C) or percent positive cells (B). Five different zones for each liver section were analyzed (n = 3 for
all the strains). Data across littermate control mice for E230 and E226 were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM.
****-P < 0.0001, *-P < 0.1. Magnification 20X, scale bars: 50 µm.
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Liver inflammation was also evident from increased infiltration of
ITGAM/CD11b-positive leukocytes (Figure 6C). In contrast,
livers from the atg16l1E230 mice showed little sign of damage. A
comparison of the mice suggested that LAP was not required to
suppress tissue damage because the liver parenchyma damage,
hepatocellular hypertrophy (Figure 6A) and raised serum GPT/
ALT levels (Figure 5C) seen in the atg16l1E226 mice, were absent
from atg16l1E230 mice. Furthermore, hepatocyte proliferation
(Figure 6B) was comparable to that found in littermate controls.
There was evidence of low level inflammatory cell infiltration in
the livers from atg16l1E230 mice (Figure 6C), possibly indicating a
role for LAP in reducing inflammation, but levels of ITGAM/
Cd11b-positive cells were much lower than seen in livers of
autophagy-defective atg16l1E226 mice.
Muscle and kidney
The atg16l1E226 mice showed evidence of muscle wasting
because the gastrocnemius muscle was significantly smaller
in atg16l1E226 mice when muscle weight was expressed as a
percentage of body weight (Figure 7A). Lysates from muscle
had high levels of SQSTM1 and LC3 (Figure 7B), and when
normalized for GAPDH expression, muscle lysates from the
atg16l1E226 mice showed 2–3 fold increases in LC3-I, and
nearly 6-fold increases in SQSTM1 compared to control
mice (Figure 7C), suggesting impaired clearance of autophagy
substrates ‘in vivo’. This was consistent with histological sec-
tions of muscle showing multiple SQSTM1 inclusions
(Figure 7D). Morphological analysis of muscle did not, how-
ever, reveal the degenerative changes observed in mice lacking
ATG7 in muscle tissue [25], such as vacuolated and centrally
nucleated myofibers.
The kidneys of atg16l1E226mice weighed less than controls, but
this difference was not statistically significant when expressed as a
percentage of body weight (Figure 8A). Kidney lysates of
atg16l1E226 mice contained raised levels of LC3-I and SQSTM1
(Figure 8B and C) and histological sections of kidney showed
multiple SQSTM1 inclusions (Figure 8D). We were not, however,
able to find evidence of obvious kidney damage and glomerular
architecture remained intact. In contrast to the autophagy-nega-
tive atg16l1E226 mice, the muscle and kidney of LAP−deficient
atg16l1E230 mice were of comparable size to littermate controls
(Figures 7A and 8A) and blots of tissue lysates did not show raised
levels of LC3-I or SQSTM1 (Figures 7B and 8B), consistent with
the absence of SQSTM1 inclusions in tissue sections (Figures 7D
and 8D). As seen for liver, tissue homeostasis in kidney andmuscle
required autophagy, but did not require the WD domain of
ATG16L1 and was, therefore maintained independently of LAP.
Brain
The autophagy-defective atg16l1E226mice showed a range of neu-
rological defects including loss of motor coordination, abnormal
limb clasping and an unusual splayed gait suggesting defects in
both the peripheral and central nervous system (data not shown).
The neurological phenotype of autophagy-defective atg16l1E226
mice mirrored the loss of motor coordination seen in mice defi-
cient inATG7 in the central nervous system [26]. The brains of the
atg16l1E226 mice were smaller than littermate controls, but there
was no significant differencewhen brainweightswere expressed as
a percentage of body weight (Figure 9A). There were high levels of
SQSTM1 in brain lysates (Figure 9B and C), and brain sections
showed evidence of SQSTM1 inclusions (Figure 9D). In contrast,
brain lysates from the LAP-deficient atg16l1E230mice had levels of
LC3-I and SQSTM1 similar to controls (Figure 9B and C), and
brains lacked SQSTM1 inclusions (Figure 9D). Although motor
coordination appeared normal in the majority of the atg16l1E230
mice, some developed head tilt suggesting defects in the inner ear
or possible ear infection.
Figure 7. Analysis of muscle. (A) Gastrocnemius muscle weight expressed as a percentage of body weights at 2–3 months of age. E230 (atg16l1E230) n = 6, control
n = 5; E226 (atg16l1E226) n = 8, control n = 6. (B) Western blot of muscle lysates from 3 representative mice. Membrane strips taken from the appropriate molecular
weight range were analyzed separately by western blot using the indicted antibodies. (C) Bar graphs show levels of LC3 and SQSTM1 relative to GAPDH. (D)
Histochemical sections of muscle were immunostained with antibodies against SQSTM1. Enlarged regions of interest are shown in the lower panels. Arrows: SQSTM1
inclusions. Statistical analysis was done by unpaired t test. Error bars represent ±SEM. ***-P < 0.001, **-P < 0.01; ns, non-significant. Magnification 20X, scale bar:
50 µm.
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Mice with systemic loss of ATG16L1 from all tissues (atg16l1−/-)
die at birth from a suckling defect [15]. This raised the question
of how the atg16l1E226 mice, which appear autophagy-defective,
survive neonatal lethality. Neonatal lethality in atg5−/- mice can
be reversed by brain-specific re-expression of ATG5 [24]. These
rescued mice (atg5-null) lack ATG5 and autophagy in non-neu-
ronal tissues and develop multiple organ abnormalities with a
phenotype closely resembling the atg16l1E226 mouse described
here. Both the atg5-null and atg16l1E226 mice, survived neonatal
lethality, but grew slowly compared to control mice, and have
pronounced hepatomegaly and sarcopenia. This makes it possi-
ble that atg16l1E226 mice described in our study survive neonatal
lethality because they carry out a low level of autophagy in the
brain. Interestingly, the LC3-I levels in the brain of atg16l1E226
mice were the same as controls (Figures 9B and 9C). This was in
contrast to peripheral tissues such as liver (Figure 5D), muscle
(Figure 7B and C) and kidney (Figure 8B and C) where LC3 was
elevated 3-4 fold. The preservation of control levels of LC3-I in
atg16l1E226 mice suggest that LC3 may be degraded in the brain
by autophagy. This observation, and the striking similarity in
phenotype with the neuronal-specific rescue of atg5-null mice
described by Yoshii et al [24], suggests that the brain of atg16l1-
E226 mice may compensate for the loss of autophagy arising from
loss of the E230 residue required for WIPI2 binding. The size
exclusion analysis of liver extracts in Figure 2 showed the elution
of WIPI2 in high molecular-weight fractions in mice expressing
full-length ATG16L1 or the CCD of ATG16L1 that retained
glutamate E230 required for WIPI2 binding, but not in mice
expressing the ATG16L1E226 CCD lacking E230. This provides
an indirect assay for binding of WIPI2 to ATG16L1 when gel
Figure 8. Analysis of kidney. (A) Kidney weights at 2–3 months expressed (i) directly: E230 (atg16l1E230 n = 8, control n = 8, E226 (atg16l1E226) n = 7, control = 8; or as
(ii) percentage body weight: E230 (atg16l1E230 n = 9, control n = 8, E226 (atg16l1E226) n = 7, control = 6. (B) Western blot of kidney lysates from 3 representative mice.
Membranes strips taken from the appropriate molecular weight range were analyzed separately using the indicted antibodies. (C) Bar graphs show levels of LC3 and
SQSTM1 relative to GAPDH. (D) Histochemical sections of kidneys immunostained for SQSTM1. (G) Indicates glomerulus. Enlarged regions of interest are shown in
lower panels. Arrows: SQSTM1 inclusions. Data from control mice were pooled. Statistical analysis was done by unpaired t test. Error bars represent ±SEM.
***-P < 0.001, **-P < 0.01; ns, non-significant. Magnification 20X, scale bars: 50 µm.
Figure 9. Analysis of brain. (A) Brain weights at 2–3 months expressed (i) directly: E230 (atg161E230 n = 8, control n = 7, E226 (atg16l1E226) n = 7, control = 7; or (ii) as
percentage body weight: E230 (atg161E230 n = 8, control n = 9, E226 (atg16l1E226) n = 6, control = 5. (B) Western blot of brain lysates from 3 representative mice.
Membrane strips taken from the appropriate molecular weight range were analyzed separately by western blot using the indicted antibodies. (C) Bar graphs show
levels of LC3 and SQSTM1 relative to GAPDH. (D) Histochemical sections of brains were immunostained for SQSTM1. Enlarged regions of interest are shown in lower
panels. Arrows indicate SQSTM1 inclusions. Data from control mice were pooled. Statistical analysis was done by unpaired t test. Error bars represents ±SEM.
***-P < 0.001, *-P < 0.1; ns, non-significant. Magnification 20X, scale bars: 50 µm.
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filtration was repeated for brain lysates (Figure 10). As seen in
liver, ATG16L1 in control mice eluted in high molecular-mass
fractions suggesting formation of a 300- to 600-kDa complex.
These same fractions contained the ATG12–ATG5 conjugate,
but surprisingly these fractions did not contain WIPI2, which
eluted between 50 and 100 kDa (Figure 10). Similarly, the
ATG16L1E230 and ATG16L1E226 CCDs formed high molecular-
weight complexes and co-eluted with ATG12–ATG5 but were
unable to move WIPI2 to high molecular-weight fractions. The
profiles resembled that seen for the ATG16L1E226 CCD in liver
that lacks the E230 glutamate required for WIPI2 binding
(Figure 2). Taken together the results suggested that the binding
of ATG16L1 to WIPI2 differs in brain compared to liver. This
may provide the basis for a low level of autophagy in brain that
allows the atg16l1E226 mice to survive neonatal lethality.
Discussion
We have generated mice lacking the WD and linker domains
of ATG16L1 to study the roles played by autophagy and LAP
in maintaining tissue homeostasis in vivo. The atg16l1E230
mice were unable to activate LAP, but retained glutamate
E226 and E230 in the CCD required for WIPI2 binding and
could therefore activate autophagy. These mice grew at the
same rate as littermate controls, were fertile and did not have
obvious defects in liver, kidney, brain or muscle homeostasis.
This suggests that autophagy rather than LAP plays a major
role in reducing tissue damage in vivo. The WD domain of
ATG16L1 in higher eukaryotes including insects, nematodes,
Figure 10. Analysis of ATG16L1 complexes in brain by gel filtration. The cytosolic fraction of brain homogenates was separated by size-exclusion chromatography on
an ENrichTMSEC 650 column. Fraction (0.5 ml) were analyzed by immunoblot for ATG16L1, ATG5 and WIPI2 as indicated. Void volume 10 ml. Migration and elution of
molecular mass standards are shown (kDa).
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plants and humans contains over half the amino acids of the
66-kDa protein [21]. Gel filtration analysis suggested that full-
length ATG16L1 formed a 300- to 600-kDa complex in liver
and brain. The CCDs of the atg16l1E230 and atg16l1E226 mice
eluted over a broad size ranging from 50–400 kDa suggesting
multimeric assembly in the absence of the WD domain. These
results are consistent with previous gel filtration analysis [21]
demonstrating 600- to 800-kDa complexes of ATG16L1 in
lysates of liver, brain and fibroblast cell lines, and the forma-
tion of additional smaller complexes ranging between 100 and
300 kDa in fibroblasts expressing ATG16L1 lacking the WD
domain. Initial calculations based on gel filtration suggest
formation of complexes containing 8 copies of ATG16L1
bound to the ATG12–ATG5 conjugate [21]. Later work ana-
lyzing the ATG16L1 complex by sucrose gradient sedimenta-
tion suggests ATG16L1 exists as a dimer [27]. This
discrepancy in size estimation could be explained if
ATG16L1 adopted an elongated conformation in solution
accelerating its elution from gel filtration columns.
Regardless of the precise size of complexes formed by
ATG16L1 and the CCDs of the atg16l1E230 and atg16l1E226
mice, all three co-eluted with ATG12–ATG5. This increase in
apparent size of the 72 kDa ATG12–ATG5 conjugate suggests
the conjugate binds all 3 CCDs via the N-terminal ATG5
binding domain. The binding of WIPI2 to ATG16L1 requires
glutamate E230 in the CCD, which is absent in the CCD of
the atg16l1E226 mice. The lack of elution of WIPI2 in high
molecular-weight liver fractions containing the CCD of the
atg16l1E226 mouse suggested that loss of glutamate E230
results in reduced WIPI2 binding in vivo.
The WD domains of ATG16L1 represent as much as a
third of the total protein. It is perhaps remarkable that this
complex of 7 bladed β-propellers, which are thought to pro-
vide a platform for protein-protein interactions important for
autophagy, play little role in maintaining tissue homeostasis
‘in vivo’. Instead, evolution appears to have confined this
important role to the N-terminal ATG5 binding and CC
domains conserved through to the yeast ortholog Atg16
[28]. Binding of ATG16L1 to WIPI2 requires glutamate resi-
dues E226 and E230 in the ATG16L1 CCD, which bind
arginine R108 and R125 exposed on the surface of WIPI2.
Deletion of either E226 or E230 in ATG16L1 abrogates bind-
ing to WIPI2, and expression of WIPI2 lacking R108 and
R125 is unable to reconstitute LC3 recruitment to phago-
phores in WIPI2-depleted cells [18]. Our study shows that
the integrity of this WIP2 binding site within the short
N-terminal domain is critical for autophagy in vivo, because
loss of one amino acid, E230, required for WIPI2 binding,
results in loss of autophagy and results in multiple tissue
abnormalities.
Macrophages and fibroblasts cultured from mice lacking
the WD domain were unable to activate LAP. This is in
agreement with previous work [22], showing that the WD
domain is required for several noncanonical pathways that
recruit LC3-II to endocytic compartments. These include
newly formed macropinosomes, phagosomes containing
latex beads or apoptotic corpses, endosomes swollen by mon-
ensin or a combination of ammonium chloride and the
vacuolating toxin A from Helicobacter pylori, and endosomes
targeted by the M2 proton channel encoded by influenza
virus. Furthermore, loss of the WD domain from ATG16L1
in dendritic cells results in reduced secretion of TNF and IL1B
in response to CLEC4N/Dectin2 signalling [23] and reduced
antigen presentation by dendritic cells [22]. The requirement
of the WD domain for LAP suggests that the scaffold pro-
vided by the WD domains of ATG16L1 has evolved a specia-
lized role, independent of autophagy, to ensure the quality
control of endocytic pathways by conjugating LC3 to phago-
somes containing pathogens or apoptotic cells, or endocytic
compartments showing signs of damage. This is supported by
the observation that the WD domain of ATG16L1 binds
NOD-like receptors [29], MEFV/TRIM20 [30], TMEM59
[31] and EVA1A/TMEM166 [32], which are important in
pathogen recognition. Our observation that mice remain
viable and maintain tissue homeostasis over long periods in
the absence of the WD domain suggests that LAP does not
play an essential role in preventing tissue damage in vivo. LAP
in phagocytic cells requires RUBCN and CYBB/NOX2 [3] and
mice with Lyz2/LysM-cre-targeted disruption of either of these
genes in macrophages, monocytes and neutrophils, grow
slowly. We did not observe slowed growth for the atg16l1E230
LAP-defective mice suggesting that loss of LAP from all
tissues allows mice to compensate for loss of LAP in phago-
cytic cells. Alternatively, the deletion of the WD domain, and
loss of RUBCN and CYBB/NOX2, inactivate LAP by different
mechanisms. ATG16L1 is downstream of RUBCN and CYBB/
NOX2, and it will be interesting to determine if the WD
domain interacts with RUBCN or UVRAG or components
of the CYBB/NOX2 complex. Defective clearance of apoptotic
cells following LAP deficiency resulting from lack of CYBB/
NOX2 or RUBCN in phagocytic cells predisposes mice to an
autoimmune disease resembling systemic lupus erythemato-
sus [4]. At 52 wk, rubcn−/- mice have increased levels of
antibody against double-stranded DNA, anti-nuclear antibo-
dies and deposition of immune complexes in the kidney. Our
analysis of LAP-deficient atg16l1E230 mice at 20–24 wk did not
show elevated cytokines or anti-nuclear antibodies (not
shown), but this does not preclude development of lupus-
like autoimmunity as they age further.
MEFs cultured from atg16l1E226 mice were unable to activate
autophagy in response to starvation, and the mice showed accu-
mulation of SQSTM1 in vivo. These mice grew slowly, were
infertile and showed defects in liver, brain and muscle home-
ostasis, and neurological defects similar to those reported for
mice with analogous tissue-specific loss of autophagy genes.
These mice again highlight the importance of autophagy for
maintaining tissue health in vivo, but, surprisingly, the atg16l1E226
mice were able to survive neonatal lethality. These mice therefore
differ from mice with systemic deletion of Atg3, Atg5, Atg12 or
Atg16l1, which die within hours of birth because they cannot
compensate for loss of placental nutrition [12,14,15]. This suggests
that the truncated CCDE226 may provide functions that are miss-
ing when Atg16l1 is deleted completely. The CCDE226 retains the
ATG5 binding domain allowing the CCD E226 to bind the
ATG12–ATG5 conjugate and assemble into an ATG12–ATG5-
ATG16L1 CCDE226 complex. This complex may maintain E3
ligase activity and be able to facilitate lipidation of LC3 and
autophagosome formation at a low level. Evidence for a low
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level of autophagy is provided in Figure 3A where accumulation
of SQSTM1 in MEFs from atg16l1E226 appeared lower than fol-
lowing complete loss of ATG16L1, and there was a feint band for
LC3-II. In addition, the requirement for WIPI2 binding to
ATG16L1 to initiate autophagy may differ between brain and
peripheral tissues. Support for this is provided by gel filtration
analysis which suggested that binding of WIPI2 to the E230
glutamate residue in the CCD of ATG16L1 occurred in liver,
but binding was much weaker in brain.
The phenotype of the atg16l1E226 mouse was very similar
to the atg5-null mouse described by Yoshii et al [24] where
ATG5 expression was restored in the brain of atg5−/- mice.
In common with atg16l1E226 mice, the atg5-null mouse
survived neonatal lethality but grew slowly and showed
SQSTM1 accumulation in peripheral tissues, particularly
liver and muscle. The atg5-null mice were sterile and have
the pronounced hepatomegaly seen in atg16l1E226 mice.
This makes it possible that a low level of autophagy in the
brain of atg16l1E226 mice allows them to survive neonatal
lethality. Indirect evidence for this is provided by the obser-
vation that LC3-I levels were not raised in the brains of
atg16l1E226 mice (Figure 8B) compared to muscle
(Figure 6B), liver (Figure 4D) and kidney (7B). The trun-
cated CCDE226 is able to protect against neonatal lethality,
but not able to provide long-term protection against neu-
rological defects. This phenotype is similar to the mice
lacking ATG7 in the central nervous system [26] where
neurons accumulate SQSTM1 inclusions and ubiquitin,
and Purkinjie cells and pyramidal neurons are lost from
the cerebellar cortex.
Materials and methods
Construction of the targeting vector
A P1 artificial chromosome (PAC) mouse genomic DNA
library (Source BioScience, 711_RPCI21mPAC) was
screened with a 0.5-kb Xho I-Sal I fragment obtained from
the Atg16l1 IMAGE cDNA clone 6,813,377/AV130 A2
(Source BioScience). A 10-kb XhoI and a 13-kb BamHI
fragment, containing exons 1–10 of Atg16l1, were subcloned
into pBSIISK- (Agilent, 212,206). Two stop codons and
restriction sites for NheI, XhoI, EcoRV and EcoRI were
introduced into exon 6 after amino acid position 230 by
PCR. Two 1.5-kb fragments were generated using primer
pairs CCAAATCCAGGTACCTCTCAG.seq in combination
with ATCCTCGAGATCGATGCTAGCCTACTATTCCTTT
GCTGCTTCTGCAAG.rev and ATCGATCTCGAGGATA
TCGAATTCCCTCTACCTGTTGAACAGTG.seq in combi-
nation with CCTGGCCCGGGCATGATAATG.rev, followed
by an annealing PCR of the 2 fragments using primers
CCAAATCCAGGTACCTCTCAG.seq and CCTGGCCCG
GGCATGATAATG.rev to generate a 3-kb fragment, which
was cloned into a SmaI-cut pUC19 vector (Addgene,
50,005). The bovine growth hormone polyadenylation site
(bGH-pA; derived from pPGK-Cre-bpA, Addgene, 11,543)
was cloned into the blunt-ended XhoI site, followed by
cloning the blunt-ended PGK-Neo-frt cassette [33] into
EcoRV. A KpnI-SmaI fragment of an 8.7-kb SacI-SmaI
fragment, generated from the 10-kb XhoI and 13-kb
BamHI genomic clones, was then exchanged with the mod-
ified exon 6-containing genomic PCR fragment.
Embryonic stem cells and generation of homozygous
mice
Embryonic stem cells were cultured as described previously
[34]. R1 cells (2x107) [35] were electroporated with 30 µg
NotI-linearized targeting vector as described. G418-resistant
clones were screened by Southern hybridization for homolo-
gous recombination. Positive clones were expanded, re-ana-
lyzed by Southern blot analysis and PCR, and injected into
C57L/B6 blastocysts. Highly chimeric male founder mice were
obtained, which were crossed with C57LB/6 females to obtain
heterozygous F1 offspring. The neomycin cassette was
removed by crossing F1 offspring with FlpO transgenic mice
[36] and mice were subsequently crossed onto a C57L/B6
background. Genotype analysis was performed using primers
CAAATATGCCTTCAGAACTG and GCTGTAGTTCCAA
TCCCTAA, resulting in 290-bp and 640-bp fragments for
wild-type and mutant mice, respectively.
Mice
These studies used adult male and female mice of approxi-
mately 2–3 months of age from the first cross of 129 and
C57BL/6. All experiments were performed in accordance with
UK Home Office guidelines and under the UK Animals
(Scientific procedures) Act1986. The growth rate of these
mice was estimated by recording weights each week. Mice
were killed by schedule-1 procedures and dissected to harvest
brain, liver, gastrocnemius muscle and kidney. The weights of
the organs were recorded before fixing or freezing.
Cells and cell culture
MEFs were generated by serial passage of cells taken from
mice at embryonic day 13.5 and cultured in DMEM
(ThermoFisher scientific, 11,570,586) with 10% FCS.
BMDMs were generated from bone marrow isolated from
femur and tibia flushed with RPMI 1640 (Sigma, R8758).
Macrophages were generated by culturing adherent cells in
RPMI 1640 containing 10% FCS and CSF1/M-CSF
(Peprotech, 315–02; 30 ng/ml) for 6 d. Macrophage popula-
tions were quantified by FACS using antibodies against
FCGR3/CD16-FCGR2B/CD32, ADGRE1/F4/80 and ITGAM/
CD11b (BioLegend, 101,320, 123,107).
Autophagy and LC3-associated phagocytosis
Autophagy was activated by incubating cells in HBSS
(ThermoFisher, 11,550,456) to create starvation for 2 h at
37°C. LAP was stimulated in bone marrow-derived macro-
phages by Pam3CSK4-coupled beads. Carboxyl-modified
beads (polybead carboxylate 3.0 µm, 09850) were conjugated
with Pam3csk4 (invivogen, TLRL-PMS) by following the
manufacturer’s protocol (Bangs Laboratories, Inc. Tech Note
205, III.). Pam3CSK4-coupled beads were added to
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macrophage cultures at a ratio of 10:1 (bead/cell) for 1.5 h
before being fixed and the location of LC3 analyzed by immu-
nofluorescence microscopy.
Tissue western blotting
Dissected tissue was snap-frozen in liquid nitrogen, ground to
a fine powder under liquid nitrogen and lysed in RIPA buffer
(150 mM sodium chloride, 1% TritonX-100 [Sigma, P1379-
1L], 0.5% sodium deoxycholate [Sigma, D-5670], 0.1% sodium
dodecyl sulfate [Fisher Bioreagents, BP166-500], 50 mM Tris,
pH 8.0) containing protease (Sigma, P8340) and phosphatase
(Sigma, P5726) inhibitors followed by homogenization and
freeze thaw. Samples were clarified by centrifugation
(10,600 g, 10 min at 4°C). Supernatants containing ̴ 10 ug
protein were boiled in Laemmli buffer followed by SDS-
PAGE using 4–12% gradient gels (Expedeon, NBT41212).
The resolved proteins were electro-blotted onto nitrocellulose
membrane (Bio-Rad, 1,620,115), blocked (5% skimmed milk
in 1X TBS [50mM Tris (pH 7.5), 150mM NaCl], 1 h, room
temperature) and then probed first with appropriate primary
(ATG16L1 [MBL, M150-3], SQSTM1/p62 [Abcam, ab91526],
GAPDH [Abcam, ab9482] and LC3A/B [Cell Signalling
Technology, 4108]) and then secondary antibody (Cell
Signalling Technology, 7074S and 7076S). Blots were visua-
lized by exposure to Supersignal West Pico chemiluminescent
substrate (ThermoFisher Scientific, 34,080). Bands were quan-
tified through ImageJ (NIH, USA), analyzed (unpaired t-test)
and plotted via GraphPad prism 7 software.
Cell western blotting
Protein was extracted using M-PER (ThermoFisher Scientific,
78,501) with complete protease inhibitor cocktail (Sigma,
04693159001) for 30 min on ice. Samples were clarified by
centrifugation (10,600Xg, 10 min). From the supernatants, pro-
tein concentrations were determined using the BCA protein
assay system (ThermoFisher Scientific, 23,225) according to the
manufacturer’s protocol. Protein (20 µg) was separated on a
precast 4–12% gradient SDS-PAGE gel (Expedeon, NBT41212)
and transferred to immobilon PVDF (Millipore, IPFL00010) for
blotting. Membranes were probed using antibodies for
ATG16L1 (MBL), SQSTM1/p62, (Abcam), LC3A/B and
ACTB/actin (Sigma, A5441). Primary antibodies were detected
using IRDye labelled secondary antibodies (LI-COR biosciences,
926–32,211, 926–68,020) at 1∶10,000 dilution. Proteins were
visualized using the Odyssey infrared system (LI-COR).
Gel filtration chromatography
Freshly dissected livers and brains were suspended in cold
phosphate-buffered saline (Oxoid, BR0014G) containing
protease inhibitors (Roche, 05892791001) and homogenized
using a Dounce homogenizer. Particulate material was
removed by sequential centrifugation at 100Xg and
13,000Xg (4°C) for 20 min. The supernatants were clarified
by ultracentrifugation (100,000Xg, 4°C, 1 h) and analyzed
by the gel filtration using an ENrichTMSEC 650 (Bio-Rad,
780–1650,) column and AKTA purifier (GE Healthcare) to
collect 0.5-ml fractions. Fractions were analyzed by SDS-
PAGE followed by western blotting on PVDF membranes
probed for ATG16L1, ATG5 (Abcam, ab108327) and WIPI2
(Abcam, ab101985). The void volume (Vo) was estimated
using Blue dextran (Sigma, D4772-1VL) and the elution
volumes (Ve) of molecular size standards (Sigma,
MWGF1000) allowed the determination of Ve: V0 ratios to
create a standard curve.
Cytokine assays
Serum from young (2–3 months) and aged (5–6 months) mice
were analyzed for cytokines using ProcartaPlexTM Simplex
Immunoassay kits (ThemoFisher Scientific, EPX01A-26,015–
901, EPX01A-20,603–901, EPX01A-26,004–901, EPX01A-
26,005–901, EPX01A-20,607–901 and EPX01A-26,002–901) by
following the manufacturer’s instructions. Samples were read on
a Luminex TM 100/200TM instrument (Luminex Corp.).
Histochemistry
Dissected tissues were fixed in 10% neutral buffer formalin
(Sigma, HT501128), dehydrated, paraffin embedded and sec-
tioned (5-µm thickness) prior to staining in hematoxylin and
eosin (H&E). For immunohistochemistry deparaffinized and
rehydrated sections were subjected to microwave-based anti-
gen retrieval in citrate buffer (~ 0.24% trisodium citrate dihy-
drate, ~ 0.038% citric acid, in water). The sections were then
incubated in hydrogen peroxide buffer (10% H2O2 in metha-
nol) to mask any background peroxidase activity followed by
treatment with blocking solution (10% goat serum [Gibco,
16,210–072], 0.30% Triton X-100 in PBS). Sections were
stained with appropriate primary (anti SQSTM1/p62 anti-
body, anti MKI67/Ki67 antibody [Abcam, ab66155], anti
ITGAM/Cd11b antibody [Abcam, ab133357]) and secondary
antibodies (anti rabbit-HRP; Dako, K4003). The signals were
developed with chromogen buffer (Dako, K3468). Tissue sec-
tions were mounted using cover glass and mounting medium
(Neomount; Merck, 1,090,160,100) and imaged using 20X and
40X objectives on a bright-field microscope (Zeiss). The
images were analyzed using Axio Vision software (cell cir-
cumference measurement, Axio Vision SE64 Rel. 4.8) and
ImageJ software (cell counter plugin, NIH, USA). The
obtained data were analyzed (unpaired t test) and plotted
through GraphPad prism 7 software.
Fluorescence imaging
Cells grown on glass coverslips were fixed at −20°C in ice cold
methanol for 7 min, then blocked in 5% goat serum, 0.3% Triton
X-100 in PBS (Sigma, G9023; X100). Cells were incubated with
anti LC3A/B (Cell Signalling Technology, 4108; 1:500 in 1% BSA
[Europa Bioproducts Ltd., EQBAH62-1000], 0.3% Triton X-100
in PBS). Washed cells were incubated with secondary antibody
anti-rabbit-Alexa Fluor 488 (Life Technologies, A11008) and
counterstained with 4ʹ, 6 diamidino-2-phenylindole (DAPI;
ThermoFisher Scientific, 10,116,287) and mounted on slides
with Fluoromount-G from Southern biotech (ThermoFisher
Scientific, 15,586,276). Cells were imaged on a Zeiss Imager
610 S. RAI ET AL.
M2 Apotome microscope with a 63X, 1.4 NA oil-immersion
objective using 365 ± 40 nm excitation and 445 ± 25 nm emis-
sion for DAPI, 470 ± 20 nm excitation and 525 ± 25 nm emission
for LC3. Images were obtained using a Zeiss Axioplan micro-
scope with bright field.
Statistics
Unpaired t test was employed for the data analysis across all
the experiments. The data were analyzed and plotted through
GraphPad prism 7 software.
Microscopy
All the fluorescent imaging was carried out using an Apotome
microscope from Zeiss, fitted with 63X objective. All the immu-
nohistochemistry for bright-field imaging was carried out using
an Axioplan 2 microscope from Zeiss, fitted with 20X, 40X
objectives and a colored Axio Cam HRc camera from Zeiss.
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